![]() |
- Condition: Penicillin Allergy
Intervention: Drug: Amoxicillin
Sponsor: Clalit Health Services
Not yet recruiting - Conditions: Insulin Sensitivity; Sleep; Dietary Habits
Intervention: Behavioral: Sleep Extension
Sponsor: University of Colorado, Denver
Recruiting - Condition: GERD
Intervention: Drug: Citalopram 20mg
Sponsor: Universitaire Ziekenhuizen Leuven
Not yet recruiting - Condition: Allergic Reaction
Intervention: Procedure: Skin test endpoint titration
Sponsor: University of Saskatchewan
Not yet recruiting - Conditions: Muscle Atrophy; Insulin Sensitivity
Interventions: Other: Bed Rest; Other: Reconditioning
Sponsor: University of Nottingham
Recruiting - Conditions: Tumor Disease Including Colorectal Cancer; Head & Neck Squamous Cell Carcinoma
Intervention:
Sponsor: Yonsei University
Recruiting - Conditions: NASH - Nonalcoholic Steatohepatitis; Insulin Sensitivity
Intervention: Device: Electro-muscular stimulation using NeuroTrac MyoPlus 2/4
Sponsor: NHS Tayside
Recruiting - Conditions: Overactive Bladder Syndrome; Bladder Outlet Obstruction; Benign Prostate Enlargement; Stress Incontinence (Female) (Male); Bladder Disease
Intervention: Other: IPSS questionnaire
Sponsor: Assaf-Harofeh Medical Center
Recruiting - Condition: Chronic Low Back Pain
Interventions: Behavioral: Culturally sensitive pain education; Behavioral: Standard pain education program
Sponsor: Hacettepe University
Not yet recruiting - Conditions: Muscle Hypersensitivity; Pain Response; Healthy Subjects
Intervention: Drug: NGF/Isotonic saline
Sponsor: Aalborg University
Recruiting - Condition: Prostate Adenocarcinoma
Intervention: Diagnostic Test: F-18 fluciclovine-PET/CT scan
Sponsors: University of Arizona; Blue Earth Diagnostics, Ltd; Banner University Medical Center
Not yet recruiting - Condition: Atopic Diseases
Interventions: Other: Hydrolyzed Formula; Other: Control formula
Sponsor: HiPP GmbH & Co. Vertrieb KG
Not yet recruiting - Condition: Training Group, Sensitivity
Intervention: Device: Microcurrent
Sponsors: University of Greenwich; Arc Family
Recruiting - Condition: IgE-mediated Milk Allergy
Intervention: Other: Milk
Sponsor: Hospital San Carlos, Madrid
Not yet recruiting - Condition: Food Allergy
Interventions: Drug: Glucopyranosyl Lipid A (GLA); Drug: Sublingual Immuno Therapy (SLIT) Peanut Extract (PE); Drug: Placebo for GLA; Drug: Placebo for SLIT PE
Sponsor: Sanofi
Not yet recruiting - Condition: NSTEMI - Non-ST Segment Elevation MI
Intervention:
Sponsors: Marco Marchetti; Azienda Ospedaliero Universitaria Maggiore della Carita; Azienda Sanitaria Locale ASL 6, Livorno; Azienda Ospedaliera Spedali Civili di Brescia; Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico; Ospedale Civile - Padova; S. Andrea Hospital; Azienda Policlinico Umberto I; San Carlo Public Hospital, Potenza, Italy; Azienda Ospedaliero-Universitaria Consorziale; Policlinico Universitario, Catania; Azienda Ospedaliera Sant'Anna; Ospedale di Cattinara - Azienda Universitaria Integrata -Trieste; Abbott s.r.l.; InformaPRO s.r.l.
Recruiting - Conditions: Visceral Hypersensitivity; Irritable Bowel Syndrome
Intervention: Drug: Rifaximin
Sponsors: Cedars-Sinai Medical Center; Valeant Pharmaceuticals International, Inc.
Not yet recruiting - Condition: Cow Milk Allergy
Intervention: Diagnostic Test: skin prick test - specific serum IgE
Sponsor: Assiut University
Not yet recruiting - Condition: Tuberculosis, Pulmonary
Interventions: Drug: Rifampicin; Drug: Isoniazid; Drug: Pyrazinamide; Drug: Ethambutol; Drug: Linezolid; Drug: Clofazimine; Drug: Rifapentine; Drug: Levofloxacin; Drug: Bedaquiline
Sponsors: University College, London; National University Hospital, Singapore; Singapore Clinical Research Institute (SCRI)
Recruiting - Conditions: Diabetes Mellitus; Endocrine System Diseases; Glucose Metabolism Disorders; PreDiabetes; Obesity
Interventions: Drug: GSK2256294; Drug: Placebo oral capsule
Sponsor: Vanderbilt University Medical Center
Not yet recruiting - Condition: Papillary Thyroid Cancer
Intervention: Drug: Imatinib Oral Tablet
Sponsors: AHS Cancer Control Alberta; Alberta Cancer Foundation
Not yet recruiting - Condition: EGFR-sensitive Mutation-positive Advanced Non-squamous Non-small Cell Lung Cancer Treated With S-1plus Gefitinib Versus Gefitinib Monotherapy
Interventions: Drug: S-1 plus Gefitinib; Drug: Gefitinib
Sponsor: Henan Cancer Hospital
Not yet recruiting - Conditions: Diabetes Mellitus, Type 2; Insulin Resistance; Insulin Sensitivity
Intervention: Drug: Intralipid, 20% Intravenous Emulsion
Sponsor: University of Pennsylvania
Not yet recruiting - Condition: Allergy Milk
Interventions: Dietary Supplement: extensively hydrolyzed casein formula + LGG; Dietary Supplement: Hypoallergenic formula based on amino-acid based formula
Sponsor: Federico II University
Not yet recruiting - Condition: Epilepsy
Intervention: Other: Measure of emotional stressors
Sponsor: University Hospital, Toulouse
Recruiting - Condition: NSCLC
Intervention:
Sponsor: K2 Oncology, Inc.
Recruiting - Condition: Allergy
Interventions: Combination Product: Streptococcus salivarius 24SMBc + Strept. oralis 89a; Combination Product: fluticasone + mometasone; Other: placebo
Sponsor: Federico II University
Not yet recruiting - Condition: Allergic Conjunctivitis
Interventions: Drug: Reproxalap Ophthalmic Solution (0.25%); Drug: Reproxalap Ophthalmic Solution (0.5%); Drug: Vehicle Ophthalmic Solution
Sponsor: Aldeyra Therapeutics, Inc.
Recruiting - Condition: Chronic Spontaneous Urticaria
Intervention: Drug: Nucala
Sponsors: Mayo Clinic; GlaxoSmithKline
Not yet recruiting - Conditions: Aspirin-Sensitive Asthma With Nasal Polyps; Samter's Syndrome
Interventions: Dietary Supplement: Water; Dietary Supplement: Red wine; Dietary Supplement: Polyphenolic Compounds
Sponsor: University of Virginia
Not yet recruiting - Clinical Endpoint Bioequivalence Study of Fluticasone Propionate & Salmeterol Xinafoate (100mg/50mg)Condition: Asthma
Interventions: Drug: Fluticasone/Salmeterol; Drug: Advair Diskus 100/50 Dry Powder Inhaler; Drug: Placebo
Sponsors: West-Ward Pharmaceutical; Pharm-Olam International
Not yet recruiting - Condition: Insulin Sensitivity
Interventions: Drug: Metformin; Drug: Pioglitazone; Drug: Placebo
Sponsor: Wayne State University
Not yet recruiting - Condition: Allergic Conjunctivitis
Interventions: Drug: EM-100; Drug: Zaditor®; Drug: Vehicle
Sponsors: EyeMax, LLC; Eton Pharmaceuticals, Inc.; ORA, Inc.
Recruiting - Conditions: Plasmodium Falciparum Malaria; Pregnancy Malaria; Diagnoses Disease
Intervention: Diagnostic Test: HS-RDT
Sponsors: Foundation for Innovative New Diagnostics, Switzerland; Burnet Institute; Papua New Guinea Institute of Medical Research
Not yet recruiting - Condition: Atopic Dermatitis
Interventions: Drug: MABp1 Monoclonal Antibody 200 mg; Drug: MABp1 Monoclonal Antibody 400 mg
Sponsor: XBiotech, Inc.
Not yet recruiting - Condition: Childhood Asthma With Status Asthmaticus
Interventions: Drug: Salbutamol; Drug: Sodium Chloride 0.9%
Sponsor: Erasmus Medical Center
Recruiting - Condition: Eosinophilic Gastritis
Interventions: Drug: AK002; Other: Placebo
Sponsor: Allakos, Inc.
Not yet recruiting - Conditions: Healthy Volunteers; Anti-Bacterial Agents; Methicillin-Resistant Staphylococcus Aureus; Methicillin-Sensitive Staphylococcus Aureus Infection
Interventions: Biological: N-Rephasin® SAL200; Other: INT200-Placebo
Sponsor: Intron Biotechnology, Inc.
Recruiting - Condition: Ovarian Cancer
Intervention: Drug: Trabectedin + PLD
Sponsors: Suriya Yessentayeva; Johnson & Johnson
Recruiting - Condition: Keratopathy
Intervention: Procedure: keratoplasty
Sponsor: Zhongshan Ophthalmic Center, Sun Yat-sen University
Recruiting - Condition: Hypertension
Intervention: Diagnostic Test: WatchBP Office (BP measurement machine)
Sponsor: Chinese University of Hong Kong
Not yet recruiting - Conditions: Atopic Dermatitis; Pruritus; Sleep Disturbance
Intervention:
Sponsors: University of Rochester; Pfizer
Not yet recruiting - Condition: Allergic Conjunctivitis
Interventions: Drug: Bilastine Ophthalmic Solution 0.6%; Drug: Ketotifen Ophthalmic Solution 0.025% (Zaditen); Drug: Vehicle of Bilastine Ophthalmic Solution
Sponsors: Faes Farma, S.A.; ORA, Inc.
Recruiting - Condition: Asthma
Intervention: Behavioral: Internet-CBT for anxiety-related asthma
Sponsor: Karolinska Institutet
Not yet recruiting - Conditions: Hereditary Angioedema; HAE
Interventions: Drug: BCX7353 capsules; Drug: Placebo oral capsule
Sponsor: BioCryst Pharmaceuticals
Recruiting - Conditions: Chronic Eczema; Psoriasis; Atopic Dermatitis
Intervention: Combination Product: ACE CSD
Sponsor: Ace Cells Lab Limited
Not yet recruiting - Condition: Social Cognition
Intervention:
Sponsor: University Hospital, Basel, Switzerland
Recruiting - Condition: Pleural Effusion
Interventions: Device: Mini-thoracoscopy; Device: Conventional rigid thoraoscopy
Sponsor: Postgraduate Institute of Medical Education and Research
Recruiting - Conditions: Childhood Asthma; Childhood Anxiety Disorder; Childhood Depression
Intervention: Behavioral: COPE for Asthma
Sponsors: Ohio State University; American Nurses Foundation; Sigma Theta Tau International/Midwest Nursing Research Society; National Association of Pediatric Nurse Practitioners; Sigma Theta Tau Epsilon Branch
Recruiting - Conditions: Breast Adenocarcinoma; Recurrent Breast Carcinoma; Recurrent Hodgkin Lymphoma; Recurrent Mycosis Fungoides; Recurrent Non-Hodgkin Lymphoma; Recurrent Primary Cutaneous T-Cell Non-Hodgkin Lymphoma; Refractory Hodgkin Lymphoma; Refractory Mycosis Fungoides; Refractory Nodal Marginal Zone Lymphoma; Refractory Non-Hodgkin Lymphoma; Refractory Primary Cutaneous T-Cell Non-Hodgkin Lymphoma; Stage IV Breast Cancer AJCC v6 and v7
Interventions: Drug: Belinostat; Drug: Carfilzomib; Biological: Daratumumab; Drug: Fludeoxyglucose F-18; Drug: Gemcitabine Hydrochloride; Other: Laboratory Biomarker Analysis; Biological: Nivolumab; Biological: Obinutuzumab; Biological: Pembrolizumab; Procedure: Positron Emission Tomography; Biological: Rituximab; Drug: Romidepsin; Other: Saline; Biological: Trastuzumab
Sponsors: Mayo Clinic; National Cancer Institute (NCI)
Recruiting - Conditions: Hematologic Diseases; Treatment
Intervention: Diagnostic Test: ex-vivo drug response assay
Sponsors: University Hospital Heidelberg; German Cancer Research Center
Not yet recruiting - Condition: Asthma
Interventions: Drug: Placebo DPI; Device: ELLIPTA DPI; Other: Ease of use questionnaires
Sponsor: GlaxoSmithKline
Not yet recruiting - Condition: Asthma
Interventions: Drug: Itraconazole Powder; Drug: Itraconazole 200 mg
Sponsor: Pulmatrix Inc.
Recruiting - Condition: Neutrophilic Asthma
Intervention: Diagnostic Test: Induced sputum
Sponsors: Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau; Spanish Clinical Research Network - CAIBER
Recruiting - Conditions: Celiac Disease; Gluten Sensitivity; Gluten Enteropathy; Gastrointestinal Disease; Digestive System Disease; Diet Modification; Intestinal Disease; Malabsorption Syndromes; Patient Compliance; Diagnostic Self Evaluation; Quality of Life
Intervention: Device: Immunochromatographic lateral flow test
Sponsors: Boston Children’s Hospital; Glutenostics, LLC
Not yet recruiting - Condition: GI Patients on Oxaliplatin Containing Regimen
Intervention: Drug: Oxaliplatin
Sponsor: Abramson Cancer Center of the University of Pennsylvania
Recruiting - Condition: Severe Asthma
Interventions: Drug: Randomisation to omalizumab; Drug: Randomisation to mepolizumab
Sponsors: Cliniques universitaires Saint-Luc- Université Catholique de Louvain; University Hospital, Ghent; University Hospital of Liege; CHU de Charleroi; Erasme University Hospital; Centre Hospitalier Universitaire Dinant Godinne - UCL Namur; Universitair Ziekenhuis Brussel; Brugmann University Hospital; Grand Hôpital de Charleroi; AZ Delta Roeselare; Centre Hospitalier Universitaire Saint Pierre; Katholieke Universiteit Leuven
Not yet recruiting - Conditions: Anhedonia; Depression; Anxiety
Interventions: Behavioral: Positive Affect Treatment; Behavioral: Negative Affect Treatment
Sponsors: University of California, Los Angeles; Southern Methodist University
Recruiting - Condition: Dermatologic Disease
Intervention: Diagnostic Test: Serum serotonin level
Sponsor: Assiut University
Not yet recruiting - Conditions: Non-Alcoholic Fatty Liver Disease; Insulin Resistance
Interventions: Dietary Supplement: L-Carnitine tartrate; Dietary Supplement: Meal Replacement Drink; Dietary Supplement: Maltodextrin
Sponsors: University of Nottingham; Nottingham University Hospitals NHS Trust; National Institute for Health Research, United Kingdom
Recruiting - Condition: Prostate Cancer Metastatic
Intervention: Drug: Rucaparib
Sponsor: Sidney Kimmel Comprehensive Cancer Center
Not yet recruiting - Conditions: MTA; Calcium Hydroxide; Dental Crown
Interventions: Procedure: Temporary cement based on Calcium Hydroxide; Procedure: MTA temporary cement
Sponsor: Federal University of Uberlandia
Recruiting - Conditions: MTA; Dental Restoration, Temporary
Interventions: Procedure: Carie removal; Procedure: Relative isolation; Procedure: Manipulation of the temporary material based on Zinc Oxide and Eugenol; Procedure: Manipulation of the temporary material based on Mineral trioxide aggregate; Procedure: Material insertion on the cavity; Procedure: Finishing the temporary direct restoration
Sponsor: Federal University of Uberlandia
Not yet recruiting - Condition: Eosinophilic Gastritis or Gastroenteritis
Interventions: Biological: Benralizumab; Biological: Placebo
Sponsors: Children's Hospital Medical Center, Cincinnati; AstraZeneca
Recruiting - Condition: Eosinophilic Asthma
Interventions: Drug: ANB020; Drug: Placebo
Sponsor: AnaptysBio, Inc.
Recruiting - Condition: Asthma, Allergic
Interventions: Drug: CMAB007; Drug: Symbicort; Drug: Seretide; Drug: Ventolin; Drug: placebo
Sponsor: Shanghai Biomabs Pharmaceutical Co., Ltd.
Recruiting - Conditions: Hereditary Angioedema; HAE; Prophylaxis
Intervention: Drug: BCX7353
Sponsor: BioCryst Pharmaceuticals
Recruiting - Condition: Microbiota
Interventions: Drug: Methimazole Pill; Drug: Propylthiouracil Pill
Sponsor: First Affiliated Hospital of Harbin Medical University
Recruiting - Condition: Primary Pterygium
Intervention: Procedure: Pterygium surgery
Sponsor: Zhongshan Ophthalmic Center, Sun Yat-sen University
Recruiting - Condition: Tooth Sensitivity
Interventions: Device: Experimental: • Group LA; Device: Placebo Comparator: • Group LA-P; Other: Experimental: • Group DE; Other: Placebo Comparator: • Group DE-P; Other: Experimental: • Group RGI; Other: Experimental: Group RX
Sponsor: University of Sao Paulo
Recruiting - Conditions: Atopic Dermatitis; Atopic Disorders; Eczema; Atopic Eczema
Intervention: Other: Participant choice of over-the-counter emollients: Vaseline, Vanicream, CeraVe Healing Ointment, CeraVe cream, Cetaphil cream
Sponsors: Oregon Health and Science University; University of Wisconsin, Madison; University of Colorado, Denver; Duke University
Not yet recruiting - Condition: Seasonal Allergic Rhinitis (SAR)
Interventions: Drug: GSP 301 NS; Drug: GSP 301 Placebo NS
Sponsor: Glenmark Specialty S.A.
Recruiting - Conditions: Pruritus; Atopic Dermatitis
Interventions: Drug: Orvepitant; Drug: Placebo
Sponsor: Nerre Therapeutics Ltd.
Not yet recruiting - Condition: Asthma
Interventions: Drug: Salmeterol Xinafoate and Fluticasone Propinate Powder; Drug: Seretide
Sponsor: Jiangsu Chia-tai Tianqing Pharmaceutical Co.,Ltd
Recruiting - Conditions: Suxamethonium Sensitivity; Aspiration of Gastric Contents Into Respiratory Tract, Part Unspecified
Intervention:
Sponsor: University Hospital, Caen
Recruiting - Condition: Insulin Sensitivity
Intervention: Other: Hi GI
Sponsors: Purdue University; Federico II University; University of Agriculture Science, Uppsala, Sweden
Recruiting - Condition: Bladder Cancer
Intervention: Device: BladderLight®
Sponsors: Cambridge University Hospitals NHS Foundation Trust; Cytosystems Ltd
Not yet recruiting - Condition: Atopic Dermatitis
Interventions: Drug: Topical coal tar; Drug: Topical corticosteroids
Sponsor: Radboud University
Recruiting - Condition: Asthma
Intervention:
Sponsor: Heart of England NHS Trust
Not yet recruiting - Condition: Obese, Pre-diabetics
Interventions: Behavioral: High-intenstiy interval training; Dietary Supplement: Insulinogenic, carbohydrate-rich drink
Sponsors: Maastricht University; Netherlands Organisation for Scientific Research
Not yet recruiting - Condition: Asthma, Allergic
Interventions: Procedure: Bronchoscopy/BAL; Procedure: Airway Brushing; Procedure: Endobronchial Biopsy
Sponsors: Andrew D. Luster, M.D.,Ph.D.; National Institute of Allergy and Infectious Diseases (NIAID)
Not yet recruiting - Conditions: Penicillin Allergy; Pediatric Emergency Medicine
Intervention: Drug: Amoxicillin
Sponsor: Medical College of Wisconsin
Recruiting - Conditions: Myopia, Progressive; Atropine Allergy
Intervention: Drug: eye drops
Sponsor: Chang Gung Memorial Hospital
Recruiting - Condition: Asthma
Interventions: Drug: Foster 100/6mg NEXThaler; Drug: Foster 100/6mg pMDI
Sponsor: Chiesi Farmaceutici S.p.A.
Recruiting - Condition: Obesity
Intervention: Behavioral: Health Smart for Weight Loss
Sponsors: University of Florida; Patient-Centered Outcomes Research Institute
Not yet recruiting - Conditions: Coronary Artery Disease; Anesthesia
Interventions: Procedure: transcutaneous acupoint electrical stimulation; Procedure: sham transcutaneous acupoint electrical stimulation
Sponsor: Hebei Medical University Third Hospital
Recruiting - Condition: Chronic Urticaria
Interventions: Procedure: Punch Biopsy; Procedure: Blood sampling
Sponsor: Olivier Michel
Recruiting - Conditions: Asthma; Mastocytosis; Mast Cell Activation Syndrome; Food Allergy; Chronic Idiopathic Urticaria; Anaphylaxis; Eczema
Intervention:
Sponsors: Hong Kong Sanatorium & Hospital; Chinese University of Hong Kong; Stanford University
Not yet recruiting - Condition: Non-Germline BRCA Mutated Ovarian Cancer
Intervention: Drug: Olaparib
Sponsors: AstraZeneca; Quintiles, Inc.; Myriad Genetics, Inc.; Covance; Theradex; Parexel
Recruiting - Condition: Cough
Intervention: Drug: Ambroxol Hydrochloride
Sponsors: Hull and East Yorkshire Hospitals NHS Trust; Sanofi
Not yet recruiting - Conditions: Asthma; COPD
Intervention: Behavioral: Inhaler technique education
Sponsor: Aveiro-Aradas Family Health Unit
Not yet recruiting - Condition: High Functioning Autism Spectrum Disorder
Intervention:
Sponsor: Rambam Health Care Campus
Not yet recruiting - Condition: Chronic Urticaria
Intervention: Biological: AK002
Sponsor: Allakos, Inc.
Recruiting - Condition: Chronic Spontaneous Urticaria
Interventions: Drug: Ligelizumab; Drug: Placebo
Sponsor: Novartis Pharmaceuticals
Not yet recruiting - Condition: Asthma
Interventions: Behavioral: ASMAS; Behavioral: Asthma education plus child health
Sponsors: Rhode Island Hospital; University of Puerto Rico
Not yet recruiting - Conditions: Renal Insufficiency, Chronic; Chronic Kidney Diseases
Intervention: Other: salt restriction education
Sponsor: Peking University First Hospital
Not yet recruiting - Condition: Eosinophilic Esophagitis
Intervention: Device: MRI to detect inflammation and fibrosis in subjects with EoE
Sponsor: Mayo Clinic
Recruiting - Condition: Rhinitis, Allergic
Interventions: Drug: loratadine + pseudoephedrine sulfate (BAY818725/Claritin-D); Drug: Placebo tablet; Drug: Fluticasone Propionate; Drug: Placebo spray
Sponsor: Bayer
Recruiting - Conditions: Advanced Malignancies; Urothelial Carcinoma; MSI-H or dMMR Solid Tumors; Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma
Interventions: Drug: Apatinib; Drug: Pembrolizumab
Sponsors: University of Utah; LSK BioPartners Inc.
Not yet recruiting - Condition: Atopic Dermatitis
Interventions: Biological: Lebrikizumab; Drug: Placebos
Sponsor: Dermira, Inc.
Recruiting - Conditions: Cataracts; Visual Acuity Reduced Transiently; Loss of Visual Contrast Sensitivity; Functional Visual Loss
Interventions: Device: Alcon 1 piece SA60AT lens; Device: AMO 1-piece AABOO lens
Sponsors: University of Toronto; Kensington Eye Institute
Recruiting - Condition: Atopic Dermatitis
Intervention: Device: BAY987534
Sponsor: Bayer
Not yet recruiting - Condition: Asthma in Children
Interventions: Other: asthma action plan management group; Other: conventional management group
Sponsors: Beijing Children's Hospital; Tian Jing Children’s Hospital; Capital Institute of Pediatrics, China; Peking University Third Hospital; Beijing Tsinghua Chang Gung Hospital; Tianjin Medical University Second Hospital; Peking University Bin Hai Hospital; The First Hospital of Qinhuangdao; Tangshan Maternal and Child Health Hospital; Children's Hospital of Hebei Province
Not yet recruiting - Condition: Severe Asthma
Intervention:
Sponsors: Massachusetts General Hospital; National Heart, Lung, and Blood Institute (NHLBI)
Not yet recruiting - Conditions: Plasma Cell Leukemia; Recurrent Plasma Cell Myeloma; Refractory Plasma Cell Myeloma
Interventions: Procedure: Biospecimen Collection; Device: High Throughput Screening; Other: Laboratory Biomarker Analysis
Sponsors: University of Washington; National Cancer Institute (NCI)
Recruiting - Condition: Atopic Dermatitis
Interventions: Drug: Baricitinib; Drug: Placebo
Sponsors: Eli Lilly and Company; Incyte Corporation
Recruiting - Condition: Atopic Dermatitis
Interventions: Drug: SB414 2%; Drug: SB414 6%; Drug: Vehicle
Sponsors: Novan, Inc.; Novella Clinical
Recruiting - Condition: Cold Hypersensitivity
Interventions: Drug: Sipjeondaebo-tang Granule; Drug: Placebo
Sponsors: Gachon University Gil Oriental Medical Hospital; Kyunghee University Oriental Medical Center; Kyung Hee University Hospital at Gangdong; Semyung University second affiliated oriental medical hospital at Chungju; Sangji University Oriental Medical Hospital
Recruiting - Conditions: EGFR Gene Mutation; Non Small Cell Lung Cancer Stage IIIA; Non Small Cell Lung Cancer Stage IIIB
Intervention: Drug: Icotinib
Sponsor: Betta Pharmaceuticals Co.,Ltd.
Recruiting - Conditions: Anxiety Disorders; Anxiety; Tobacco Dependence; Smoking, Cigarette; Smoking, Tobacco
Interventions: Behavioral: Personalized Feedback Intervention; Behavioral: Smoking Information Control
Sponsors: University of Houston; National Institute on Drug Abuse (NIDA)
Recruiting - Condition: Atopic Dermatitis
Interventions: Drug: Baricitinib; Drug: Placebo; Drug: Topical corticosteroid
Sponsors: Eli Lilly and Company; Incyte Corporation
Not yet recruiting - Condition: Dermatitis, Atopic
Intervention: Drug: Dupilumab
Sponsors: Regeneron Pharmaceuticals; Sanofi
Not yet recruiting - Conditions: Asthma; COPD; Asthma-COPD Overlap Syndrome
Intervention: Other: No any intervention
Sponsor: Mahidol University
Recruiting - Condition: Allergic Hypersensitivity Drug Reaction Versus Non-allergic Hypersensitivity Drug Reaction Cross Reaction
Intervention:
Sponsor: University Hospital, Grenoble
Recruiting - Conditions: Asthma; Child; Respiratory Disease; Hydrotherapy; Respiratory Tract Diseases; Respiratory Hypersensitivity; Respiration Disorders
Interventions: Other: Ai Chi; Other: Asthma education
Sponsor: Universidade Federal do Rio Grande do Norte
Recruiting - Conditions: Wheezing; Reactive Airway Disease; Mild Asthma
Interventions: Combination Product: VR647 Inhalation Suspension (budesonide) 1 mg/2 mL delivered by the VR647 Inhalation System; Combination Product: 1 mg/2 mL Pulmicort Respules delivered by a conventional jet nebulizer
Sponsor: Vectura Limited
Recruiting - Condition: Dermatitis, Atopic
Interventions: Drug: PF-04965842 100 mg; Drug: PF-04965842 200 mg; Drug: Placebo
Sponsor: Pfizer
Recruiting - Condition: Lung Cancer
Intervention: Drug: Gefitinib
Sponsors: Qilu Pharmaceutical Co., Ltd.; China-Japan Friendship Hospital; Beijing Cancer Hospital; Cancer Institute and Hospital, Chinese Academy of Medical Sciences; Chinese PLA General Hospital
Not yet recruiting - Condition: Food Allergy
Intervention: Dietary Supplement: Oral immunotherapy
Sponsor: Helsinki University Central Hospital
Recruiting - Condition: Asthma
Interventions: Other: Peak Expiratory Flow Rate (PEFR); Other: Standard Clinical Judgement
Sponsor: Minneapolis Medical Research Foundation
Recruiting - Condition: Chemotherapy Effect
Intervention: Drug: Chemotherapy, Cancer, Anthracyclines
Sponsor: Assiut University
Not yet recruiting - Condition: Sensitivity, Contact
Interventions: Drug: ATx201; Drug: ATx201 Placebo Gel
Sponsor: AntibioTx A/S
Recruiting - Condition: Dentin Sensitivity
Interventions: Drug: Dentifrice containing 5% w/w KNO3 and 0.454% w/w SnF2 (1100 ppm fluoride).; Drug: Dentifrice containing 0.454% w/w SnF2 (1100 ppm fluoride).
Sponsor: GlaxoSmithKline
Not yet recruiting - Condition: Asthma
Intervention: Other: Asthma Subspecialty Follow-up Visits
Sponsor: Arkansas Children's Hospital Research Institute
Recruiting - Condition: Atopic Dermatitis
Intervention: Drug: RVT-501 0.5% topical ointment
Sponsor: Dermavant Sciences GmbH
Recruiting - Condition: Chemotherapy Effect
Interventions: Other: Stiper; Other: acupuncture; Other: Control
Sponsor: Federal University of São Paulo
Recruiting - Condition: Wheat Allergy
Intervention: Dietary Supplement: Wheat spaghetti
Sponsor: Athens General Children's Hospital "Pan. & Aglaia Kyriakou"
Recruiting - Condition: Asthma
Interventions: Biological: Tezepelumab; Other: Placebo
Sponsors: AstraZeneca; Amgen
Recruiting - Conditions: Asthma; Healthy
Intervention: Other: Observational
Sponsor: University of Pennsylvania
Recruiting - Conditions: Perioperative/Postoperative Complications; Drug-Induced Anaphylaxis
Intervention:
Sponsor: Assiut University
Recruiting - Condition: Food Allergy
Interventions: Behavioral: Behavioral intervention group; Behavioral: Education
Sponsor: Icahn School of Medicine at Mount Sinai
Recruiting - Condition: Peanut Allergy
Intervention: Drug: DBV712 IHRP
Sponsor: DBV Technologies
Recruiting - Condition: Non Alcoholic Steatohepatitis
Interventions: Dietary Supplement: Hesperidin; Other: control
Sponsor: National Nutrition and Food Technology Institute
Recruiting - Condition: Non Alcoholic Steatohepatitis
Interventions: Dietary Supplement: hesperidin and flaxseed; Other: control
Sponsor: National Nutrition and Food Technology Institute
Recruiting - Conditions: Vasculitis; Systemic Vasculitis; Behcet's Disease; CNS Vasculitis; Cryoglobulinemic Vasculitis; Eosinophilic Granulomatous Vasculitis; Temporal Arteritis; Giant Cell Arteritis; Granulomatosis With Polyangiitis; Wegener Granulomatosis; Henoch Schonlein Purpura; IgA Vasculitis; Microscopic Polyangiitis; Polyarteritis Nodosa; Takayasu Arteritis; Urticarial Vasculitis
Intervention: Other: Online Questionnaire
Sponsor: University of Pennsylvania
Recruiting - Condition: Atopic Dermatitis
Intervention: Other: narrow-band UVB
Sponsor: Oslo University Hospital
Recruiting - Condition: Metastatic Hormone-Sensitive Prostate Cancer
Interventions: Drug: docetaxel 50mg/m2; Drug: docetaxel 75mg/m2
Sponsor: Peng Wang
Not yet recruiting - Conditions: Cardiovascular Diseases; Hypertension
Intervention: Drug: Torasemide 5Mg Tablet
Sponsors: NHS Greater Glasgow and Clyde; University of Glasgow; British Heart Foundation
Recruiting - Condition: COPD Asthma
Intervention:
Sponsor: Association Nationale pour les Traitements A Domicile, les Innovations et la Recherche
Not yet recruiting - Condition: Bronchial Asthma
Interventions: Drug: Fluticasone propionate/salmeterol 100/50 µg; Other: Placebo; Drug: Advair Diskus 100/50 Dry Powder Inhaler, 60 ACTUAT
Sponsor: Cipla Ltd.
Not yet recruiting - Condition: Asthma
Interventions: Drug: GSK3772847; Drug: Placebo
Sponsor: GlaxoSmithKline
Not yet recruiting - Condition: Infected Atopic Dermatitis/Eczema
Interventions: Drug: Fucicort® Lipid cream; Drug: Fucidin® cream; Drug: Fucicort® Lipid cream vehicle; Drug: betamethasone (Lianbang Beisong®) cream
Sponsor: LEO Pharma
Not yet recruiting - Condition: Atopic Dermatitis
Interventions: Drug: RVT-501 0.5% ointment; Drug: Vehicle ointment
Sponsor: Dermavant Sciences GmbH
Recruiting - Condition: Food Allergy
Intervention: Behavioral: mediterranean diet
Sponsor: Federico II University
Recruiting - Condition: Neck Pain
Interventions: Other: Patients with chronic neck pain; Other: Subjects without chronic neck pain
Sponsor: Peking University People's Hospital
Not yet recruiting - Condition: Asthma in Children
Intervention: Other: Nurse-delivered education
Sponsors: University of Rochester; New York State Department of Health
Not yet recruiting - Condition: Prostate Adenocarcinoma
Interventions: Drug: Leuprolide Acetate; Drug: Goserelin Acetate; Radiation: Stereotactic Body Radiation Therapy; Radiation: Radium Ra 223 Dichloride; Other: Laboratory Biomarker Analysis
Sponsor: City of Hope Medical Center
Recruiting - Conditions: Allergic Asthma; Airway Remodelling; Extracellular Matrix Alteration
Interventions: Procedure: Bronchial challenge with allergen; Other: Co-culture formation; Other: Inhibition of Wnt and Smad signaling pathways; Other: Extracellular matrix turnover and deposition assessment; Biological: Dermatophagoides pteronyssinus allergen; Device: Dosimeter ProvoX (Ganshorn); Biological: Eosinophils; Biological: Airway smooth muscle cells; Biological: Fibroblasts
Sponsors: Lithuanian University of Health Sciences; Research Council of Lithuania; University of Groningen
Recruiting - Condition: Atopic Dermatitis (AD)
Interventions: Drug: Dupilumab; Drug: Placebo
Sponsors: National Institute of Allergy and Infectious Diseases (NIAID); Regeneron Pharmaceuticals; Sanofi; Atopic Dermatitis Research Network
Not yet recruiting - Condition: Severe Asthma
Intervention:
Sponsor: AstraZeneca
Recruiting - Condition: Asthma
Interventions: Drug: Fluticasone/ Formoterol; Drug: fluticasone/ salmeterol
Sponsor: Mundipharma (China) Pharmaceutical Co. Ltd
Recruiting - Condition: Asthma
Interventions: Drug: SAR440340/REGN3500; Drug: Dupilumab; Drug: Fluticasone or Fluticasone/salmeterol combination; Drug: Placebo for SAR440340 (REGN3500); Drug: Placebo for dupilumab
Sponsors: Sanofi; Regeneron Pharmaceuticals
Recruiting - Conditions: Atopic Dermatitis; Effects of Immunotherapy
Interventions: Drug: Mite extract sublingual immunotherapy (SLIT); Other: Placebo
Sponsors: Casa Espirita Terra de Ismael; Fundação de Amparo à Pesquisa do Estado de São Paulo
Recruiting - Conditions: Sensitivity; Specificity; Histological Response; Survival
Intervention:
Sponsors: Peking University People's Hospital; Xijing Hospital; Second Affiliated Hospital, School of Medicine, Zhejiang University
Not yet recruiting - Condition: Anaphylaxis
Interventions: Combination Product: Epipen 0.3mg; Combination Product: Emerade 300mcg; Combination Product: Emerade 500mcg
Sponsor: Imperial College London
Recruiting - Conditions: Diabetes Mellitus, Type 2; Skeletal Muscle Insulin Sensitivity
Intervention: Drug: Dapagliflozin
Sponsor: AstraZeneca
Recruiting - Condition: Atopic Dermatitis Eczema
Interventions: Drug: Investigational OTC Cream; Drug: 0.05% Desonide; Other: Placebo Cream
Sponsor: Procter and Gamble
Recruiting - Condition: Eosinophilic Esophagitis
Intervention:
Sponsors: Children's Hospital Medical Center, Cincinnati; National Institute of Allergy and Infectious Diseases (NIAID); National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Office of Rare Diseases (ORD); National Center for Advancing Translational Science (NCATS)
Not yet recruiting - Conditions: Tuberculosis, Pulmonary; Tuberculosis, Multidrug-Resistant; Tuberculosis, MDR; Tuberculosis; Drug-resistant Tuberculosis; Drug-Resistant Tuberculosis, Extremely
Interventions: Drug: Pretomanid; Drug: Bedaquiline; Drug: Moxifloxacin; Drug: Pyrazinamide; Drug: HRZE; Drug: HR
Sponsor: Global Alliance for TB Drug Development
Not yet recruiting - Condition: Asthma and Allergic Rhinitis
Intervention: Drug: Montelukast 10mg
Sponsor: Clinision
Not yet recruiting - Conditions: Psoriasis; Atopic Dermatitis
Interventions: Drug: BMX-010; Drug: Placebo
Sponsor: BioMimetix JV, LLC
Recruiting - Condition: Non-ST-segment Elevation Myocardial Infarction
Intervention:
Sponsors: Beijing Anzhen Hospital; Beckman Coulter, Inc.
Recruiting - Conditions: Wheezing; Asthma in Children
Intervention:
Sponsors: HUS Skin and Allergy Hospital; Revenio Research; Mehiläinen
Recruiting - Condition: Asthma
Interventions: Drug: FF/UMEC/VI; Drug: FP/SAL; Drug: Tiotropium; Drug: Albuterol/salbutamol; Device: ELLIPTA DPI; Device: DISKUS DPI; Device: RESPIMAT inhaler; Device: Metered Dose Inhaler; Device: Connected Inhaler System
Sponsor: GlaxoSmithKline
Not yet recruiting - Condition: Allergic Conjunctivitis
Interventions: Drug: PR013 (0.045%); Drug: PR013 (0.06%); Drug: Placebo
Sponsor: Realm Therapeutics, Inc.
Recruiting - Conditions: Atopic Keratoconjunctivitis; Vernal Keratoconjunctivitis; Perennial Allergic Conjunctivitis
Intervention: Biological: AK002
Sponsor: Allakos, Inc.
Recruiting - Condition: Allergic Rhinitis
Interventions: Drug: Benjakul Extract; Drug: Loratadine
Sponsor: Thammasat University
Recruiting - Condition: Atrial Fibrillation
Intervention:
Sponsor: University Hospital Heidelberg
Recruiting - Condition: Behavior, Infant
Interventions: Behavioral: Control; Behavioral: Sensitivity Intervention; Behavioral: Couples' Intervention; Behavioral: Sensitivity and Couples' Intervention
Sponsors: University of Notre Dame; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Recruiting - Conditions: Gait Disorders, Neurologic; Gait Disorder, Sensorimotor
Intervention: Behavioral: Standard locomotor therapy
Sponsor: University of Zurich
Recruiting - Conditions: Osteoarthritis, Knee; Pain; Physical Activity; Mitochondrial Pathology
Intervention: Behavioral: Walking
Sponsors: University of Maryland; National Institute of Nursing Research (NINR)
Not yet recruiting - Condition: Atopic Dermatitis
Intervention: Other: LIPIKAR BAUME AP+ emollient
Sponsors: University of Schleswig-Holstein; Technische Universität Dresden
Recruiting - Condition: Atopic Dermatitis
Interventions: Other: TCM; Other: Western medicine
Sponsor: China Medical University Hospital
Recruiting - Condition: Allergic Rhinoconjunctivitis
Interventions: Dietary Supplement: Lertal® + standard therapy; Other: Placebo + standard therapy
Sponsor: NTC srl
Recruiting - Condition: Asthma
Intervention:
Sponsors: AstraZeneca; Parexel; MedImmune LLC
Recruiting - Conditions: Insulin Sensitivity; Endothelial Dysfunction; Blood Pressure
Interventions: Other: High Load/Low Rep Resistance Training; Other: Low Load/High Rep Resistance Training
Sponsor: Arizona State University
Recruiting - Conditions: Asthma; Pediatric ALL
Intervention: Drug: budesonide, beclomethasone
Sponsor: New York City Health and Hospitals Corporation
Recruiting - Conditions: Chronic Rhinosinusitis (Diagnosis); Asthma; Nasal Polyps
Intervention: Drug: Reslizumab
Sponsor: University of Rochester
Recruiting - Condition: Seasonal Allergic Rhinitis
Interventions: Drug: Omalizumab; Drug: Placebo
Sponsor: Novartis Pharmaceuticals
Recruiting - Condition: Cushing's Disease
Intervention: Other: [11C]-Methionine PET/MRI
Sponsor: Hospices Civils de Lyon
Not yet recruiting - Conditions: Food Allergy; Food Allergy in Infants; Food Allergy in Children; Food Allergen Sensitisation; Milk Allergy; Egg Allergy; Nut Allergy
Intervention: Diagnostic Test: Oral food challenge
Sponsors: King's College London; Guy's and St Thomas' NHS Foundation Trust
Not yet recruiting - Conditions: Prostate Cancer; Bone Metastases
Interventions: Drug: Zoledronic Acid; Drug: Enzalutamide
Sponsor: Azienda Ospedaliera Spedali Civili di Brescia
Recruiting - Condition: Asthma
Interventions: Dietary Supplement: Vitamin D; Dietary Supplement: Placebo
Sponsors: St. Justine's Hospital; Canadian Institutes of Health Research (CIHR); EURO-PHARM International Canada inc.
Not yet recruiting - Condition: Mitochondrial Diseases
Interventions: Drug: Lipitor 20Mg Tablet; Drug: Lipitor 80Mg Tablet; Drug: Placebo Oral Tablet
Sponsors: University of Kansas Medical Center; National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Recruiting - Conditions: Cough; Cough Variant Asthma; Upper-Airway Cough Syndrome; GERD; Allergic Rhinitis
Intervention: Other: Cough variant asthma treatment
Sponsor: Medical University of Warsaw
Recruiting - Condition: PreDiabetes
Interventions: Other: Egg based breakfast foods; Other: Non-egg based breakfast foods
Sponsor: Midwest Center for Metabolic and Cardiovascular Research
Recruiting - Conditions: Celiac Disease; Barrett Esophagus; Gluten Sensitivity; GERD
Intervention: Other: Gluten free diet
Sponsor: McMaster University
Not yet recruiting - Condition: Atopic Dermatitis
Interventions: Drug: Tralokinumab; Drug: Placebo
Sponsor: LEO Pharma
Recruiting - Condition: Severe Asthma
Intervention:
Sponsor: Medical University of Warsaw
Recruiting - Condition: Allergic Rhinitis
Interventions: Drug: Allergen Immunotherapy Extract; Drug: Allergen Immunotherapy Control
Sponsor: Johns Hopkins University
Recruiting - Conditions: Atopic Dermatitis; Psoriasis
Intervention:
Sponsor: University of Schleswig-Holstein
Recruiting - Conditions: Type2 Diabetes Mellitus; Stable Coronary Artery Disease
Interventions: Drug: Dapagliflozin 10Mg Tab; Other: Placebo
Sponsor: Andrea Giaccari
Recruiting - Treatment of Alopecia Areata (AA) With Dupilumab in Patients With and Without Atopic Dermatitis (AD)Condition: Alopecia Areata
Interventions: Drug: Dupilumab; Drug: Placebos
Sponsor: Icahn School of Medicine at Mount Sinai
Recruiting - Condition: Asthma
Interventions: Drug: GP MDI 28.8 μg; Drug: GP MDI 14.4 μg; Drug: GP MDI 7.2 μg; Drug: Placebo MDI; Drug: Spiriva Respimat 2.5 μg
Sponsor: Pearl Therapeutics, Inc.
Recruiting - Conditions: Nasal Polyps; Asthma, Aspirin-Induced; Aspirin-exacerbated Respiratory Disease; Aspirin-Sensitive Asthma With Nasal Polyps
Interventions: Drug: Ifetroban; Drug: Placebo
Sponsor: Brigham and Women's Hospital
Not yet recruiting - Condition: Hormone Sensitive Oligometastatic Prostate Cancer
Interventions: Procedure: Radical prostatectomy; Radiation: HDR (19Gy) or SBRT (35-40Gy)
Sponsor: Dr. Patrick Cheung
Recruiting - Conditions: Atopic Dermatitis; Psoriasis
Interventions: Drug: Ustekinumab; Drug: Infliximab; Drug: Secukinumab; Drug: Dupilumab
Sponsor: Prof. Dr. Stephan Weidinger
Recruiting - Condition: Atopic Dermatitis
Intervention: Drug: Crisaborole ointment 2%
Sponsor: Pfizer
Recruiting - Condition: Eosinophilic Esophagitis
Interventions: Device: Cytosponge; Other: Diet; Other: EEsAI Pro; Other: Likert Scoring Scale
Sponsor: Mayo Clinic
Not yet recruiting - Conditions: Acupuncture; Knee Osteoarthritis; Sensitive Acupoints; Tender Points
Intervention: Other: acupuncture
Sponsor: West China Hospital
Not yet recruiting - Condition: Atopic Dermatitis
Intervention: Drug: PR022
Sponsor: Realm Therapeutics, Inc.
Recruiting - Condition: Lymphangioleiomyomatosis
Intervention:
Sponsor: National Heart, Lung, and Blood Institute (NHLBI)
Recruiting - Condition: Allergic Rhinitis
Interventions: Drug: Resveratrol plus Carboxymethyl-β-Glucan; Drug: Placebo
Sponsor: Istituto di Biomedicina e Immunologia Molecolare Alberto Monroy
Recruiting - Condition: Asthma
Interventions: Biological: Experimental: Tezepelumab; Other: Placebo
Sponsors: AstraZeneca; Amgen
Recruiting - Conditions: African Trypanosomiases; West African; Trypanosomiasis; Sleeping Sickness; West African; Trypanosoma Brucei Gambiense; Infection
Interventions: Diagnostic Test: Rapid diagnostic test (RDT); Diagnostic Test: Serological and molecular tests on DBS
Sponsors: Institut de Recherche pour le Developpement; Ministry of Public Health, Democratic Republic of the Congo; Ministry of Health, Guinea; Institut National de Sante Publique; Institut National de Recherche Biomédicale; CIRDES; Institute of Tropical Medicine, Belgium; University of Liverpool
Recruiting - Condition: Dermatitis, Atopic
Interventions: Drug: PF-04965842 100 mg; Drug: PF-04965842 200 mg; Drug: Placebo
Sponsor: Pfizer
Recruiting - Condition: Healthy
Intervention: Device: rTMS
Sponsor: University of New Mexico
Recruiting - Conditions: Ischemic Stroke; Migraine; Migraine With Aura
Intervention: Other: questionnaire ef-ID Migraine
Sponsor: University Hospital, Montpellier
Recruiting - Condition: Asthma
Interventions: Other: Telephonic interviews; Other: E-RS: COPD; Other: Supplemental asthma items; Other: Daily diary; Other: Sociodemographic questionnaire; Other: Clinical questionnaire
Sponsors: GlaxoSmithKline; Evidera
Recruiting - Conditions: Urticaria; Allergy
Interventions: Drug: IV Dexamethasone; Drug: Oral prednisolone
Sponsor: Chulalongkorn University
Recruiting - Condition: Dermatitis, Atopic
Interventions: Drug: Dupilumab; Drug: Matching placebo
Sponsors: Regeneron Pharmaceuticals; Sanofi
Recruiting - Condition: Dermatitis, Atopic
Interventions: Drug: Dupilumab; Drug: Matching Placebo; Other: Background Treatment: Topical Corticosteroids; Other: Background Treatment: Moisturizers
Sponsors: Regeneron Pharmaceuticals; Sanofi
Recruiting - Condition: Eosinophilic Esophagitis
Intervention: Other: Transnasal esophagoscopy
Sponsors: Children's Hospital Medical Center, Cincinnati; National Institute of Allergy and Infectious Diseases (NIAID); National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Office of Rare Diseases (ORD); National Center for Advancing Translational Science (NCATS)
Recruiting - Conditions: Hypersensitivity Dentin; Tooth Hypersensitivity
Interventions: Combination Product: Sylc; Combination Product: fluoride varnish (Bifluorid 10)
Sponsor: Cairo University
Not yet recruiting - Condition: Prediabetes
Interventions: Dietary Supplement: Resistant Starch; Dietary Supplement: Placebo
Sponsor: Hospital de Clinicas de Porto Alegre
Not yet recruiting - Condition: Rhinitis, Allergic
Interventions: Procedure: Cettum; Procedure: Acupuncture
Sponsors: Eun Jung Kim; DongGuk University
Not yet recruiting - Condition: Asthma
Interventions: Dietary Supplement: Probiotical®; Other: Placebo
Sponsors: University Hospital of Liege; European Union
Recruiting - Conditions: Food Allergy; Adherence, Medication
Interventions: Behavioral: Text Message Only; Behavioral: Text message + Incentive 1; Behavioral: Text message + Incentive 2
Sponsors: University of Pennsylvania; Children's Hospital of Philadelphia
Not yet recruiting - Conditions: Allergic Rhinitis; Asthma
Interventions: Drug: Cetirizine Hydrochloride 1 MG/ML; Drug: Placebo - Concentrate
Sponsor: New York City Health and Hospitals Corporation
Not yet recruiting - Condition: Status Asthmaticus
Intervention: Drug: Ketamine
Sponsor: Augusta University
Not yet recruiting - Condition: Chronic Spontaneous Urticaria
Interventions: Drug: Omalizumab; Drug: Placebo
Sponsor: Novartis Pharmaceuticals
Recruiting - Conditions: Adhesion; Thyroidectomy
Intervention: Combination Product: MEDICLORE
Sponsors: Seoul National University Hospital; Daewoong Pharmaceutical Co. LTD.
Recruiting - Condition: Sensitive Skin
Intervention: Device: LED light
Sponsor: University Hospital, Brest
Not yet recruiting - Conditions: Asthma; Chronic School Absenteeism
Interventions: Behavioral: Home Visit; Behavioral: Standard Care
Sponsor: University of California, Davis
Recruiting - Condition: Atopic Dermatitis
Interventions: Drug: Baricitinib; Drug: Placebo
Sponsors: Eli Lilly and Company; Incyte Corporation
Recruiting - Condition: Atopic Dermatitis
Interventions: Drug: Baricitinib; Drug: Placebo
Sponsors: Eli Lilly and Company; Incyte Corporation
Recruiting - Condition: Atopic Dermatitis
Interventions: Drug: Baricitinib; Drug: Placebo
Sponsors: Eli Lilly and Company; Incyte Corporation
Recruiting - Conditions: Interstitial Lung Disease; Idiopathic Pulmonary Fibrosis; Connective Tissue Related ILD; Chronic Hypersensitivity Pneumonitis; Fibrotic Lung Disease
Interventions: Behavioral: Focus groups; Behavioral: Semi-structured interviews
Sponsors: Kingston University; St. George's Hospital, London; University College London Hospitals
Recruiting - Conditions: Celiac Disease; Wheat Hypersensitivity; Gluten Sensitivity; Gluten Enteropathy; Immune System and Related Disorders; Duodenal Diseases
Interventions: Dietary Supplement: Gluten; Dietary Supplement: Placebo
Sponsor: Mayo Clinic
Recruiting - Condition: Carious Dentin
Intervention: Procedure: Partial caries removel techniques
Sponsor: Cairo University
Not yet recruiting - Condition: Asthma, Exercise-Induced
Intervention: Drug: Benralizumab
Sponsors: Louis-Philippe Boulet; AstraZeneca
Not yet recruiting - Conditions: Asthma; Insomnia
Interventions: Behavioral: SHUTi; Behavioral: Emmi
Sponsors: University of Pittsburgh; National Heart, Lung, and Blood Institute (NHLBI)
Not yet recruiting - Condition: Asthma
Intervention: Device: Feedback using ICT based monitoring system
Sponsors: Yeungnam University Hospital; Ministry of Trade, Industry & Energy, Republic of Korea; Korea Evaluation Institute of Industrial Technology; Daegu Metropolitan City, Korea; ICT Clinical Trial Coordination Center
Recruiting - Condition: Sensitivity
Intervention: Device: Hypoxicator
Sponsor: University of Florida
Recruiting - Condition: Misoprostol Allergy
Intervention: Procedure: office hysteroscopy
Sponsor: Kasr El Aini Hospital
Recruiting - Condition: FOOD ALLERGY
Intervention: Diagnostic Test: The basophil activation test (BAT)
Sponsor: Assistance Publique Hopitaux De Marseille
Recruiting - Condition: Breast Cancer
Intervention: Drug: Denosumab Injection
Sponsor: Kyoto Prefectural University of Medicine
Recruiting - Condition: Asthma Brittle
Intervention:
Sponsors: Queen's University, Belfast; RASP (Refractory Asthma Stratification Programme); Medical Research Council; University of Oxford; University of Leicester; NHS Greater Glasgow and Clyde; Belfast Health and Social Care Trust
Recruiting - Condition: Allergic Rhinitis
Intervention:
Sponsors: Medical University of Graz; Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Not yet recruiting - Condition: Cough Variant Asthma
Intervention: Drug: Chanqin granules
Sponsor: Shanghai University of Traditional Chinese Medicine
Not yet recruiting - Condition: Asthma in Children
Interventions: Behavioral: Reach for Control; Behavioral: MATCH
Sponsors: Wayne State University; National Heart, Lung, and Blood Institute (NHLBI)
Not yet recruiting - Condition: Eosinophilic Gastroenteritis
Intervention: Other: elemental diet therapy
Sponsors: Children's Hospital Medical Center, Cincinnati; National Institute of Allergy and Infectious Diseases (NIAID); National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Office of Rare Diseases (ORD); National Center for Advancing Translational Science (NCATS)
Recruiting - Condition: Macula Hole
Intervention: Procedure: Macular hole surgery
Sponsor: Central Hospital, Nancy, France
Not yet recruiting - Condition: Acute Lymphoblastic Leukemia
Intervention: Drug: GRASPA
Sponsors: Birgitte Klug Albertsen; ERYtech Pharma
Recruiting - Conditions: Asthma; Emotional Disorder; Alexithymia
Intervention: Other: Interview and tests of drawing.
Sponsor: Hospices Civils de Lyon
Not yet recruiting - Condition: Eosinophilic Esophagitis
Intervention: Diagnostic Test: endoflip
Sponsor: Indiana University
Recruiting - Conditions: Type2 Diabetes; Type 2 Diabetes Mellitus; Insulin Sensitivity; Insulin Resistance; Depression; Adolescent Obesity
Interventions: Behavioral: Cognitive-behavioral therapy group; Behavioral: Health education group
Sponsors: Colorado State University; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); National Center for Advancing Translational Science (NCATS); Children's Hospital Colorado
Recruiting - Condition: Healthy
Interventions: Biological: Typhoid Vi Polysaccharide Vaccine; Biological: Placebo
Sponsors: University of California, San Francisco; National Institute of Mental Health (NIMH)
Not yet recruiting - Condition: Sepsis
Intervention:
Sponsors: Ludwig-Maximilians - University of Munich; City of Munich
Recruiting - Condition: Eosinophilic Esophagitis
Intervention: Device: Esophageal String Test (EST)
Sponsors: University of Colorado, Denver; Children's Hospital of Philadelphia; Children's Hospital Colorado
Not yet recruiting - Condition: Asthma
Interventions: Other: Compression Stockings; Other: Control
Sponsor: University Health Network, Toronto
Recruiting - Condition: Dentin Sensitivity
Interventions: Device: CSSP Toothpaste; Device: Fluoride Toothpaste
Sponsors: Unilever R&D; University of Bristol
Recruiting - Condition: Breast Cancer
Intervention: Biological: Blood sample
Sponsor: Institut du Cancer de Montpellier - Val d'Aurelle
Recruiting - Condition: Anaphylaxis
Interventions: Device: Part 1; Device: Part 2 Group 1; Drug: Part 2 group 2; Device: Part 2 group 3; Device: Part 2 Group 4
Sponsor: Bausch & Lomb Incorporated
Recruiting - Condition: Chronic Urticaria
Intervention:
Sponsor: Ajou University School of Medicine
Recruiting - Condition: Asthma
Interventions: Behavioral: BREATHE Intervention; Behavioral: Control Intervention
Sponsor: Columbia University
Recruiting - Condition: Bronchial Asthma
Interventions: Drug: Jia Wei Yang He granule; Drug: Jia Wei Yang He granule Placebo
Sponsors: Shanghai University of Traditional Chinese Medicine; Fudan University
Recruiting - Conditions: Asthma; Compliance, Patient; Quality of Life
Intervention:
Sponsor: Elpen Pharmaceutical Co. Inc.
Recruiting - Condition: Asthma
Interventions: Drug: CJM112; Other: Placebo to CJM112
Sponsor: Novartis Pharmaceuticals
Recruiting - Condition: Analgesia, Patient-Controlled
Interventions: Other: Tailored regimen of IV PCA according to pain sensitivity; Other: Regimen of IV PCA without considering pain sensitivity
Sponsor: Seoul National University Hospital
Recruiting - Condition: Asthma
Interventions: Behavioral: School; Behavioral: Asthma education; Behavioral: Home environmental remediation; Behavioral: Informational mail
Sponsors: Virginia Commonwealth University; National Heart, Lung, and Blood Institute (NHLBI)
Not yet recruiting - Condition: Colorectal Cancer Metastatic
Intervention: Drug: Based on sensitivity analysis
Sponsor: Vejle Hospital
Recruiting - Conditions: Asthma Acute; Asthma in Children
Interventions: Device: BiPAP; Device: CPAP; Drug: Ipratropium; Drug: Magnesium Sulfate; Drug: Aminophylline; Drug: Standard steroid dose, hourly salbutamol, oxygen as needed
Sponsors: University of British Columbia; Post Graduate Institute of Medical Education and Research, Chandigarh
Not yet recruiting - Condition: Cow Milk Allergy
Interventions: Other: Test extensively hydrolyzed formula; Other: Control extensively hydrolyzed formula
Sponsor: Nestlé
Recruiting - Condition: Asthma
Intervention: Behavioral: Weight loss intervention
Sponsors: Johns Hopkins University; American Lung Association; National Heart, Lung, and Blood Institute (NHLBI); University of Vermont; University of Arizona
Recruiting - Condition: Asthma
Intervention: Behavioral: High Intensity Interval Training
Sponsor: Bispebjerg Hospital
Recruiting - Condition: Asthma
Interventions: Biological: Mepolizumab; Drug: Placebo
Sponsors: National Institute of Allergy and Infectious Diseases (NIAID); Inner-City Asthma Consortium; GlaxoSmithKline
Recruiting - Conditions: Atopic Dermatitis; Atopic Dermatitis Eczema
Intervention: Drug: Dupilumab
Sponsors: University of California, San Francisco; Regeneron Pharmaceuticals
Not yet recruiting - Condition: Eosinophilic Esophagitis
Interventions: Diagnostic Test: Barium Esophagram; Device: EsophaCap; Diagnostic Test: Physical Examination and Questionnaires
Sponsor: Mayo Clinic
Recruiting - Conditions: Asthma; Respiratory Disease
Intervention: Other: TRACK questionnaire
Sponsors: Federal University of São Paulo; AstraZeneca
Recruiting - Conditions: Allergic Rhinitis; Allergic Rhinitis Due to Grass Pollen; Healthy Volunteers
Interventions: Biological: B244 suspension; Biological: Vehicle
Sponsors: AOBiome LLC; Orange County Research Center; Integrium
Recruiting - Conditions: Dysphagia; Stroke
Interventions: Diagnostic Test: FEES (flexible endoscopic evaluation of swallowing); Other: Sensitivity threshold; Diagnostic Test: Taste-/smell-test; Diagnostic Test: Neuropsychological testing
Sponsor: University of Giessen
Recruiting - Condition: Asthma
Interventions: Drug: GSK3511294; Drug: Placebo; Drug: Salbutamol/albuterol
Sponsor: GlaxoSmithKline
Recruiting - Condition: Stage III Colon Cancer
Interventions: Drug: Oxaliplatin; Drug: Oxaliplatin LBM
Sponsor: Institut du Cancer de Montpellier - Val d'Aurelle
Recruiting - Conditions: Rhinitis; Rhinitis, Allergic; Rhinitis, Allergic, Seasonal; Rhinitis, Allergic, Perennial
Intervention:
Sponsor: Istituto di Biomedicina e Immunologia Molecolare Alberto Monroy
Recruiting - Condition: Cow Milk Allergy
Intervention:
Sponsor: Ankara University
Recruiting - Conditions: Irritable Bowel Syndrome; Visceral Hypersensitivity
Interventions: Device: Rapid Barostat Bag; Other: IBS severity scoring system questionnaire (IBS-SSS); Other: HAD scale questionnaire
Sponsor: Queen's University
Recruiting - Condition: Asthma Chronic, Cough
Intervention: Other: Inhaled capsaicin cough challenge
Sponsor: National Health Service, United Kingdom
Recruiting - Condition: Diabetes
Interventions: Drug: Continous IV infusion of Nesiritide; Drug: Hyperinsulinemic euglycemic clamp; Drug: Placebo
Sponsor: Translational Research Institute for Metabolism and Diabetes, Florida
Recruiting - Conditions: Asthma; Late-Onset Asthma; Childhood Asthma
Interventions: Procedure: Sputum induction; Procedure: Blood sample
Sponsor: Gert Jan Braunstahl / Gerdien Tramper
Recruiting - Conditions: Apnea; Respiration Disorder
Intervention: Device: Pressure sensitive mat
Sponsors: Children's Hospital of Eastern Ontario; NSERC Collaborative Research and Development
Recruiting - Conditions: Prostate Cancer; Prostate Adenocarcinoma
Intervention: Drug: ADT+Docetaxel+Enzalutamide
Sponsors: Earle Burgess; Astellas Pharma Inc; Medivation, Inc.
Recruiting - Condition: Allergy
Intervention: Other: Human biological samples
Sponsor: Institut Pasteur
Recruiting - Condition: Sepsis, Severe
Intervention: Other: no intervention
Sponsors: Medical University of Graz; Dalian Medical University
Recruiting - Conditions: Asthma; Allergic Rhinitis
Intervention:
Sponsor: Istituto di Biomedicina e Immunologia Molecolare Alberto Monroy
Recruiting - Conditions: Asthma; Status; Asthma in Children; Asthma Acute; Asthma Attack; Acute Asthma Exacerbation
Intervention: Drug: Montelukast Oral Granules
Sponsor: Vanderbilt University Medical Center
Not yet recruiting - Condition: ALLERGIC OR HYPERSENSITIVITY
Intervention: Other: No intervention: analysis of health data from patients with
Sponsors: University Hospital, Montpellier; AstraZeneca
Recruiting - Conditions: Pain, Postoperative; Atrial Fibrillation; Cognitive Dysfunction
Intervention:
Sponsor: Duke University
Recruiting - Condition: Lamotrigine Allergy
Intervention: Drug: Lamotrigine
Sponsor: Seoul National University Hospital
Recruiting - Conditions: COPD; Asthma
Intervention: Other: No intervention
Sponsor: Chinese University of Hong Kong
Recruiting - Condition: Asthma
Interventions: Device: DragONE; Device: SmartOne
Sponsor: Istituto di Biomedicina e Immunologia Molecolare Alberto Monroy
Recruiting - Condition: Asthma
Intervention: Drug: Fluticasone propionate
Sponsor: GlaxoSmithKline
Recruiting - Conditions: PreDiabetes; Body Weight
Interventions: Drug: Empagliflozin 25mg; Drug: Placebo Oral Tablet
Sponsor: University Hospital Tuebingen
Recruiting - Condition: Psoriasis
Intervention:
Sponsor: Celgene
Recruiting - Conditions: Rheumatologic Disorder; Inflammatory Bowel Diseases; Immune Complex Diseases
Intervention: Biological: Influenza vaccine
Sponsors: Stony Brook University; University of North Carolina, Chapel Hill
Recruiting - Condition: Hypersensitivity
Intervention: Procedure: Blood test, skin testing and challenge testing.
Sponsor: The Leeds Teaching Hospitals NHS Trust
Recruiting - Conditions: Dacryocystitis; Bacteriology
Intervention: Diagnostic Test: bacterial culture and analysis
Sponsor: Sun Yat-sen University
Recruiting - Condition: Glucose Intolerance
Intervention: Drug: Carnitene (L-Carnitine or Levocarnitine)
Sponsor: Maastricht University Medical Center
Recruiting - Condition: Teeth Sensitivity
Interventions: Procedure: gull wing preparation of laminates veneers; Procedure: conventional preparation of laminates veneers
Sponsor: Cairo University
Not yet recruiting - Condition: Staphylococcus Aureus
Intervention: Other: Decolonization by nasal Octinidin treatment and skin washings
Sponsor: Charite University, Berlin, Germany
Recruiting - Condition: Small Cell Lung Cancer
Intervention: Drug: Nabpaclitaxel
Sponsors: Gruppo Oncologico Italiano di Ricerca Clinica; Temas srl; Clirest s.r.l.; Mipharm S.p.A.; Istituto Toscano Tumori - Centro per il Coordinamento delle Sperimentazioni Cliniche
Recruiting - Condition: Atopic Dermatitis
Interventions: Biological: FURESTEM-AD Inj.; Other: Placebo
Sponsor: Kang Stem Biotech Co., Ltd.
Recruiting - Condition: Atopic Eczema
Intervention: Device: Domestic ion-exchange water softener
Sponsors: King's College London; Guy's and St Thomas' NHS Foundation Trust; University of Nottingham; University of Sheffield; Imperial College London; University of Amsterdam; University of Dundee
Recruiting - Condition: Thymus and Activation Regulated Chemokine
Intervention:
Sponsor: Assiut University
Not yet recruiting - Condition: Asthma
Interventions: Behavioral: ACTION Intervention; Other: Enhanced usual care
Sponsor: University of Illinois at Chicago
Not yet recruiting - Condition: Allergic Bronchopulmonary Aspergilloses
Interventions: Device: MRI; Device: CT scan (standard reference)
Sponsor: University Hospital, Bordeaux
Not yet recruiting - Conditions: Acute Myocardial Infarction; Acute Coronary Syndrome
Intervention: Diagnostic Test: Cardiac troponin testing
Sponsors: Minneapolis Medical Research Foundation; Abbott Diagnostics Division; Hennepin County Medical Center, Minneapolis
Recruiting - Conditions: COPD, Emphysema, Asthma COPD Overlap; Emphysema
Intervention: Other: As above: diagnosis: COPD, Emphysema, Asthma-COPD Overlap
Sponsor: Gelb, Arthur F., M.D.
Recruiting - Conditions: Asthma; Breast Cancer; Stroke
Intervention: Other: Semi-structured interviews
Sponsor: Hospices Civils de Lyon
Not yet recruiting - Condition: Asthma
Interventions: Biological: PCV13; Biological: PPSV23
Sponsor: Mayo Clinic
Recruiting - Conditions: Brain Concussion; Post-Concussion Symptoms; Concussion
Interventions: Other: 3D-MOT Neurotracker; Other: Visual Attention Intervention
Sponsors: McGill University Health Center; Merck Sharp & Dohme Corp.
Recruiting - Condition: Deafness, Bilateral
Interventions: Behavioral: Parent-Child Early Approaches to Raising Language Skills; Other: Standard Care Speech therapy
Sponsors: University of Miami; National Institute on Deafness and Other Communication Disorders (NIDCD)
Recruiting - Condition: Asthma
Interventions: Drug: Indacaterol maleate; Drug: Indacaterol acetate; Drug: Placebo
Sponsor: Novartis Pharmaceuticals
Not yet recruiting - Condition: Atopic Dermatitis
Interventions: Drug: Stoss vitamin D; Drug: Daily vitamin D; Drug: Stoss placebo; Drug: Daily placebo
Sponsor: Murdoch Childrens Research Institute
Recruiting - Condition: Atopic Dermatitis
Intervention: Drug: INCB018424 phosphate cream
Sponsor: Incyte Corporation
Recruiting - Conditions: Fatty Liver, Nonalcoholic; Insulin Sensitivity
Intervention:
Sponsors: Maastricht University Medical Center; Unilever R&D
Recruiting - Condition: Mild to Moderate Atopic Dermatitis
Intervention: Behavioral: Online Treatment response
Sponsor: Wake Forest University Health Sciences
Recruiting - Condition: Asthma
Interventions: Drug: FF/VI via ELLIPTA DPI; Drug: FF via ELLIPTA DPI
Sponsor: GlaxoSmithKline
Recruiting - Conditions: Neuropathy, Painful; Chemotherapy-induced Peripheral Neuropathy; Colorectal Cancer
Interventions: Drug: Lidocaine Hydrochloride; Drug: Placebo; Drug: FOLFOX regimen
Sponsor: Washington University School of Medicine
Recruiting - Condition: Overweight
Interventions: Other: High dose vegetable juice; Other: Medium dose vegetable juice; Other: Low dose vegetable juice; Other: Control bottled water
Sponsor: USDA Grand Forks Human Nutrition Research Center
Recruiting - Conditions: Metabolic Syndrome; PreDiabetes
Interventions: Other: USDA Style Diet; Other: Lean Beef Diet
Sponsors: Midwest Center for Metabolic and Cardiovascular Research; National Cattlemen's Beef Association
Recruiting - Condition: Eosinophilic Esophagitis (EoE)
Intervention: Drug: Budesonide oral suspension
Sponsor: Shire
Recruiting - Condition: Asthma
Intervention: Other: asthmatic exacerbation
Sponsor: Chinese University of Hong Kong
Recruiting - Condition: Food Allergy
Interventions: Drug: Omalizumab; Drug: Food Flour Allergens
Sponsors: Kari Christine Nadeau; University of California, Los Angeles
Recruiting - Condition: Dentine Hypersensitivity
Interventions: Drug: 5% fluoride varnish; Drug: 8% arginine containing paste; Drug: Self-adhesive resin
Sponsor: Aga Khan University
Recruiting - Conditions: Asthma; Chest Syndrome; Clinical Anxiety; Clinical Depression; Lung Function; Quality of Life; Eosinophilia; Nitric Oxide; Airway Responsiveness; Induced Sputum
Intervention: Drug: Treat patient according to Global Initiative for Asthma (GINA) guideline
Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University
Recruiting - Condition: Hereditary Angioedema (HAE)
Interventions: Drug: BCX7353; Drug: Placebo
Sponsor: BioCryst Pharmaceuticals
Recruiting - Condition: Rheumatoid Arthritis
Interventions: Drug: Evobrutinib; Drug: Placebo; Drug: Methotrexate
Sponsors: EMD Serono Research & Development Institute, Inc.; Merck KGaA
Recruiting - Condition: Atopic Dermatitis Eczema
Interventions: Biological: B244; Biological: Vehicle
Sponsors: AOBiome LLC; Veristat, Inc.
Recruiting - Condition: Obesity
Intervention:
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Recruiting - Condition: Obesity
Interventions: Behavioral: CareMessage™; Behavioral: Control Condition
Sponsor: Washington University School of Medicine
Not yet recruiting - Condition: Taste Disorders
Intervention:
Sponsors: Hospital Israelita Albert Einstein; Coordenação de Aperfeiçoamento de Pessoal de Nível Superior.
Recruiting - Condition: Lung Diseases
Interventions: Other: functional Magnetic Resonance Imaging (research grade); Other: Cognitive Function Testing (non-diagnostic); Other: Asthma and Psychological Questionnaires (non-diagnostic)
Sponsors: University of Wisconsin, Madison; National Institutes of Health (NIH); National Heart, Lung, and Blood Institute (NHLBI)
Recruiting - Condition: Esophageal Reflux
Interventions: Drug: Chlorpromazine; Device: Multimodal stimulation probe; Drug: Placebo - Concentrate
Sponsor: Universitaire Ziekenhuizen Leuven
Not yet recruiting - Condition: Metastatic Breast Cancer
Interventions: Drug: Palbociclib; Drug: Endocrine therapy (non IMP)
Sponsor: MedSIR
Recruiting - Condition: Bronchial Asthma
Interventions: Drug: Ke Chuan Liu Wei Granule; Drug: Yang He Ping Chuan Granule; Other: Ke Chuan Liu Wei Granule placebo; Other: Yang He Ping Chuan Granule placebo
Sponsors: Shanghai University of Traditional Chinese Medicine; Longhua Hospital
Not yet recruiting - Intraperitoneal Delivery of Adaptive Natural Killer (NK) Cells (FATE-NK100) With Intraperitoneal IntConditions: Epithelial Ovarian Cancer; Fallopian Tube Cancer; Primary Peritoneal Cancer
Interventions: Biological: FATE-NK100; Drug: Interleukin-2
Sponsor: Masonic Cancer Center, University of Minnesota
Recruiting - Conditions: Anxiety Disorders and Symptoms; Depression
Interventions: Behavioral: Social Approach Training (5 sessions); Behavioral: Social Approach Training (10 sessions)
Sponsor: University of California, San Diego
Recruiting - Condition: Asthma
Interventions: Drug: QAW039; Drug: Placebo
Sponsor: Novartis Pharmaceuticals
Not yet recruiting - Conditions: Anaphylaxis; Allergy; Transfusion Reaction; Febrile Transfusion Reaction
Intervention: Diagnostic Test: Biomarkers (platelet activating factor [PAF], anaphylatoxins) and basophil activation test (BAT)
Sponsor: Haukeland University Hospital
Recruiting - Conditions: Schizophrenia; Gluten Sensitivity; Schizo Affective Disorder
Interventions: Other: Gluten Flour in Protein Shake; Other: Rice Flour in Protein Shake
Sponsor: University of Maryland
Recruiting - Condition: Stress Disorders, Post-Traumatic
Intervention: Device: HIRREM
Sponsors: Wake Forest University Health Sciences; Brain State Technologies, LLC
Recruiting - Conditions: Depression; Anxiety; Somatoform Disorders; Alcohol Abuse
Intervention:
Sponsors: Charite University, Berlin, Germany; German Federal Ministry of Education and Research
Recruiting - Condition: Peripheral Artery Disease
Intervention: Other: Data collected
Sponsor: Rennes University Hospital
Recruiting - Conditions: Antibiotic Side Effect; Eyelid; Wound; Eyelid Diseases; Surgical Wound Infection; Surgical Wound, Recent; Surgical Incision; Skin Cancer Face; Antibiotic Allergy; Surgical Site Infection
Interventions: Drug: Topical Anti-Infective Product; Drug: Topical Ointment
Sponsor: University of California, San Francisco
Recruiting - Condition: General Anesthetic Drug Allergy
Intervention:
Sponsor: Central South University
Recruiting - Conditions: Quality of Life; Ovarian Cancer; Recurrent Ovarian Carcinoma
Intervention: Other: no intervention - observational study
Sponsor: North Eastern Germany Society of Gynaecologic Oncology
Recruiting - Condition: Stomach Neoplasms
Interventions: Drug: Sunitinib; Drug: Gefitinib; Drug: Imatinib
Sponsor: Samsung Medical Center
Recruiting - Condition: Asthma
Interventions: Drug: QAW039; Drug: Placebo
Sponsor: Novartis Pharmaceuticals
Not yet recruiting - Condition: Food Allergy
Intervention: Diagnostic Test: Cytobrush
Sponsor: University of Erlangen-Nürnberg Medical School
Recruiting - Condition: Bronchial Asthma
Intervention: Drug: Corticosteroid
Sponsor: Assiut University
Not yet recruiting - Condition: Trauma
Intervention: Behavioral: Skills training of Affect-Regulation - A culture-sensitive approach: STARK
Sponsors: Ludwig-Maximilians - University of Munich; REFUGIO Munich
Recruiting - Conditions: Food Allergy; Anaphylaxis Food
Intervention: Drug: Ibrutinib
Sponsors: Ann & Robert H Lurie Children's Hospital of Chicago; Feinberg School of Medicine, Northwestern University
Recruiting - Condition: Asthma
Interventions: Drug: GSK3772847; Drug: Placebo; Drug: Fluticasone propionate/salmeterol; Drug: Fluticasone propionate
Sponsor: GlaxoSmithKline
Recruiting - Conditions: Plasmodium Falciparum; Pregnancy Malaria; Diagnoses Disease
Intervention: Diagnostic Test: HS-RDT
Sponsors: Foundation for Innovative New Diagnostics, Switzerland; Universidad de Antioquia
Recruiting - Adiponectin, IL-6 and hsC-RP in Relation to Carotid Intima-media Thickness in B-thalassemia PatientsCondition: Thalassemia
Interventions: Diagnostic Test: Interleukin-6; Diagnostic Test: HsC-RP; Diagnostic Test: Adiponectin level; Diagnostic Test: Carotid intima media thickness
Sponsor: Assiut University
Not yet recruiting - Condition: Study Genetic Basis of Infantile Onset Diabetes Mellitus
Intervention: Genetic: Human Leucocytic antigen typing and mutation of adenosine triphosphate sensitive K channel gene in diabetic patients diagnosed under the age of one year.
Sponsor: Assiut University
Not yet recruiting - Conditions: Heart Diseases; Coronary Disease; Coronary Artery Disease; Cardiovascular Diseases; Myocardial Ischemia; Artery Occlusion; Aspirin Sensitivity; Clopidogrel, Poor Metabolism of; Platelet Dysfunction; Platelet Thrombus
Interventions: Drug: Clopidogrel; Drug: Aspirin
Sponsor: University of Maryland
Not yet recruiting - Conditions: Dietary Modification; Health Behavior
Interventions: Other: ACGG; Behavioral: BCC
Sponsors: Harvard School of Public Health; International Livestock Research Institute; Addis Continental Institute of Public Health; Food, Agriculture and Natural Resources Policy Analysis Network
Recruiting - Conditions: Hyperalgesia; Pain Insensitivity, Congenital
Interventions: Device: Cold pressor test; Other: β-endorphins evaluation in saliva; Other: β-endorphins evaluation in blood plasma
Sponsor: Lithuanian University of Health Sciences
Not yet recruiting - Condition: Atopic Dermatitis
Intervention:
Sponsor: University of Arizona
Recruiting - Conditions: Hypertension Uncomplicated; Pre Hypertension
Intervention: Diagnostic Test: High and low salt diets
Sponsor: University of Minnesota - Clinical and Translational Science Institute
Recruiting - Conditions: Conjunctivitis, Allergic; Conjunctivitis, Vernal
Interventions: Drug: Hyaluronic acid 0.05% & Ectoine 2.0%; Drug: Olopatadine hydrochloride ophthalmic solution 0.1%
Sponsors: Michael Marchand, MD; Université de Montréal
Recruiting - Conditions: Diabetes Mellitus, Type II; Insulin Resistance
Interventions: Procedure: HBO; Procedure: Hyperbaric air
Sponsors: University of Adelaide; Royal Adelaide Hospital Research Committee
Not yet recruiting - Condition: Asthma
Intervention: Other: Electronic Asthma Management System: eAMS
Sponsors: St. Michael's Hospital, Toronto; Ontario Lung Association
Not yet recruiting - Condition: Bronchial Asthma
Intervention:
Sponsor: Assiut University
Not yet recruiting - Condition: Eosinophilic Esophagitis
Interventions: Drug: APT-1011; Drug: Placebo
Sponsor: Adare Pharmaceuticals, Inc.
Recruiting - Condition: Chronic Idiopathic Urticaria
Interventions: Biological: benralizumab; Biological: placebo
Sponsor: Jonathan A. Bernstein, MD
Recruiting - Conditions: Diabetes Mellitus, Type 1; Autoimmune Diseases; Diabetes Mellitus; Endocrine System Diseases; Glucose Metabolism Disorders; Immune System Diseases; Metabolic Diseases
Interventions: Drug: Glutamine vs. Placebo; Other: Exercise
Sponsor: Nemours Children's Clinic
Recruiting - Condition: Outcome After Total Knee Arthroplasty
Intervention: Procedure: total knee arthroplasty
Sponsors: University of Salford; Stockport NHS Foundation Trust
Not yet recruiting - Condition: Asthma
Intervention: Drug: Spiriva Respimat
Sponsor: Boehringer Ingelheim
Recruiting - Condition: Plasmodium Falciparum
Intervention: Diagnostic Test: ELISA validation
Sponsor: University of Oxford
Not yet recruiting - Condition: Asthma
Interventions: Behavioral: Pictorial Asthma Action Plan; Behavioral: Written Asthma Action Plan
Sponsor: West Virginia University
Recruiting - Condition: Asthma
Interventions: Drug: FF/UMEC/VI 100/62.5/25 mcg; Drug: FF/UMEC/VI 200/62.5/25 mcg; Drug: Salbutamol; Other: ACQ-7
Sponsors: GlaxoSmithKline; York Bioanalytical Solution; BI Medical.Inc; SRL Mediserch.Inc; Parexel International Japan; Q2 Solutions
Recruiting - Condition: Asthma
Interventions: Biological: Benralizumab; Biological: Placebo
Sponsor: AstraZeneca
Recruiting - Condition: Lung Cancer Stage IV
Interventions: Drug: Icotinib; Radiation: SBRT
Sponsor: Sichuan Cancer Hospital and Research Institute
Not yet recruiting - Condition: Atopic Dermatitis
Interventions: Other: CeraVe® Eczema Soothing Body Wash; Other: Cetaphil® RestoraDerm® Eczema Calming Body Wash; Other: Dove® Sensitive Skin Body Wash; Other: Eucerin® Skin Calming Body Wash; Other: Aveeno® Skin Relief Body Wash; Other: MooGoo® Milk Wash; Other: Free & Clear Liquid Cleanser
Sponsor: University of Arizona
Recruiting - Condition: Asthma
Interventions: Drug: Benralizumab (Medi-563); Drug: Placebo
Sponsor: AstraZeneca
Recruiting - Condition: Dermatitis, Atopic
Interventions: Dietary Supplement: PREBIOTICS; Other: PLACEBO
Sponsor: Nantes University Hospital
Recruiting - Condition: Advanced Malignant Neoplasm
Interventions: Dietary Supplement: Fat Emulsion; Other: Placebo
Sponsors: Mayo Clinic; National Cancer Institute (NCI)
Recruiting - Conditions: Asthma-COPD Overlap Syndrome; Asthma; COPD; Diagnoses Disease
Intervention: Diagnostic Test: Impulse Oscillometry
Sponsor: Shengjing Hospital
Recruiting - Condition: PreDiabetes
Interventions: Other: 1.5 oz of whole, natural almonds; Other: Low-fat, high refined starches/sugars
Sponsors: Midwest Center for Metabolic and Cardiovascular Research; Almond Board of California
Recruiting - Condition: Asthma
Interventions: Device: placebo Diskus®; Device: placebo Ellipta®; Device: Pulmicort® Turbuhaler®
Sponsor: University Hospital, Bordeaux
Not yet recruiting - Condition: Triple Negative Breast Cancer
Interventions: Drug: Olaparib Oral Product; Drug: Olaparib Oral Product in combination with Durvalumab
Sponsors: Kimberly Blackwell; AstraZeneca
Not yet recruiting - Conditions: Scheduled Surgery; Healthy Volunteers
Intervention: Behavioral: Psychophysical exploration
Sponsors: University Hospital, Clermont-Ferrand; Inserm U1107 « Neuro-Dol », Clermont-Ferrand, France; Centre Jean Perrin; Klinikum der Universität München, Deutschland
Recruiting - Conditions: Atopic Dermatitis; Eczema, Atopic
Interventions: Drug: ALX-101 Gel 1.5% and ALX-101 Gel Vehicle; Drug: ALX-101 Gel 5% and ALX-101 Gel Vehicle
Sponsor: Ralexar Therapeutics, Inc.
Recruiting - Condition: Chronic Urticaria
Intervention: Other: Hospital Anxiety and Depression Scale
Sponsor: Assiut University
Not yet recruiting - Condition: Allergy; Dander
Interventions: Diagnostic Test: Male dog; Diagnostic Test: Female dog
Sponsor: Copenhagen Studies on Asthma in Childhood
Recruiting - Conditions: Obesity; Insulin Resistance; Type2 Diabetes
Intervention:
Sponsors: University of Colorado, Denver; National Institutes of Health (NIH); Children's Hospital Colorado
Recruiting - Condition: Orthopaedic Trauma Infections
Intervention: Diagnostic Test: Highly Sensitive Assays
Sponsor: University of Maryland
Recruiting - Condition: Hand-foot Syndrome
Intervention: Drug: Brimonidine Tartrate
Sponsor: Heinrich-Heine University, Duesseldorf
Recruiting - Conditions: Atrial Fibrillation; Acute Kidney Injury
Intervention:
Sponsor: IRCCS Policlinico S. Donato
Recruiting - Conditions: Cataract; Traffic Accident; Vision Disorders; Driving Impaired
Intervention: Diagnostic Test: Slit lamp (LOCS III Score)
Sponsors: Aalen University; DGUV (Deutsche Gesetzliche Unfallversicherung/German Social Accident Insurance Institutions); Study Course Ophthalmic Optics and Optometry, University of Applied Sciences Aalen; Study Course Mechatronics, University of Applied Sciences Aalen; Steinbeis Transferzentrum AWFE, University of Applied Sciences Aalen; Würzburg Institute for Traffic Sciences GmbH
Recruiting - Condition: Urticaria Chronic
Intervention:
Sponsor: HaEmek Medical Center, Israel
Recruiting - Condition: Asthma
Interventions: Drug: QVM149; Drug: Salmeterol/fluticasone plus tiotropium
Sponsor: Novartis Pharmaceuticals
Recruiting - Condition: Status Asthmaticus
Interventions: Device: HFNC; Device: Standard Oxygen Treatment
Sponsor: Hospices Civils de Lyon
Not yet recruiting - Condition: Asthma Acute
Interventions: Device: NIPPV; Device: CPAP
Sponsor: National Institute of Respiratory Diseases, Mexico
Not yet recruiting - Efficacy and Safety of Ojeok-san on Korean Patients With Cold Hypersensitivity in the Hands and FeetCondition: Cold Hypersensitivity
Interventions: Drug: Ojeok-San; Drug: Placebo
Sponsors: Chan-Yong Jeon; Kyunghee University Oriental Medical Center; Kyung Hee University Hospital at Gangdong; Semyung University second affiliated oriental medical hospital at Chungju
Recruiting - Condition: Atopic Dermatitis Eczema
Intervention: Biological: Autologous Microbial Transplant
Sponsor: University of California, San Diego
Recruiting - Condition: Atopic Dermatitis (AD)
Interventions: Biological: TMT Lotion; Drug: Placebo Lotion
Sponsors: National Institute of Allergy and Infectious Diseases (NIAID); Atopic Dermatitis Research Network
Recruiting - Condition: Cow's Milk Protein Allergy
Interventions: Other: Test infant formula with HMOs; Other: Control infant formula without HMOs
Sponsor: Nestlé
Recruiting - Condition: Urticaria
Interventions: Drug: GDC-0853; Drug: Placebo
Sponsor: Genentech, Inc.
Recruiting - Conditions: Atopic Dermatitis; Eczema; Food Allergy
Interventions: Other: Evaluating atopy in infants; Other: Evaluating TEWL and STS in adults
Sponsor: National Jewish Health
Recruiting - Conditions: Acute Coronary Syndrome; Chest Pain
Intervention: Diagnostic Test: Coronary CT Angiography
Sponsor: Admir Dedic
Recruiting - Condition: Atopic Eczema
Intervention: Diagnostic Test: Skin Testing for Atopic eczema
Sponsors: Sheffield Teaching Hospitals NHS Foundation Trust; University of Sheffield
Recruiting - Condition: Type2 Diabetes Mellitus
Intervention:
Sponsor: Charles University, Czech Republic
Recruiting - Condition: Asthma
Intervention: Other: Tapering of ICS treatment
Sponsor: Hvidovre University Hospital
Not yet recruiting - Condition: Asthma
Intervention:
Sponsors: University Medical Center Groningen; GlaxoSmithKline
Recruiting - Condition: Knee Osteoarthritis
Intervention: Drug: Blinded study medication
Sponsor: Johns Hopkins University
Recruiting - Condition: Asthma
Interventions: Drug: CSJ117; Drug: Placebo Comparator
Sponsor: Novartis Pharmaceuticals
Not yet recruiting - Condition: Psoriasis
Intervention: Other: 12-week elimination diet
Sponsor: University of Michigan
Recruiting - Condition: COPD Asthma
Interventions: Device: Spirometry; Drug: Albuterol
Sponsors: University of Illinois at Chicago; Agency for Healthcare Research and Quality (AHRQ)
Recruiting - Condition: Asthma
Interventions: Other: Questionnaire; Other: Software of Big Data
Sponsors: GlaxoSmithKline; Quintiles IMS
Recruiting - Condition: Asthma
Intervention: Biological: hMSCs
Sponsor: Marilyn Glassberg
Recruiting - Condition: Asthma in Children
Intervention: Drug: Inhaled corticosteroid (mometasone)
Sponsors: University of Pittsburgh; National Heart, Lung, and Blood Institute (NHLBI)
Not yet recruiting - Conditions: Allergy; Asthma; Urticaria
Intervention:
Sponsor: University of Nebraska
Recruiting - Conditions: Diabetes Mellitus, Type 1; Gastroparesis; Dyspepsia; Gluten Sensitivity
Intervention: Other: Gluten-free diet
Sponsor: McMaster University
Recruiting - Condition: Asthma
Interventions: Drug: Dexamethasone; Drug: Prednisone
Sponsor: Children's Hospital of Eastern Ontario
Not yet recruiting - Condition: Allergic Bronchopulmonary Aspergilloses
Interventions: Drug: Glucocorticoids; Drug: Vitamin D
Sponsor: Postgraduate Institute of Medical Education and Research
Not yet recruiting - Conditions: Overactive Bladder; Overactive Detrusor; Urgency-Frequency Syndrome; UTI
Intervention: Procedure: Extended Urine Culture
Sponsor: The Cleveland Clinic
Recruiting - Conditions: HIV; Insulin Sensitivity; Diabetes Mellitus
Interventions: Drug: Zidovudine; Drug: Nevirapine
Sponsors: Icahn School of Medicine at Mount Sinai; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Recruiting - Condition: Perennial Allergic Rhinitis
Intervention: Drug: Acarovac
Sponsors: University Hospital of Cologne; Bencard Allergie GmbH
Recruiting - Condition: Dysfunctional Breathing in Asthma
Interventions: Other: Breathing Exercises; Other: Usual care
Sponsors: Naestved Hospital; Zealand University Hospital; Hvidovre University Hospital; Aalborg Universitetshospital; Bispebjerg Hospital; TrygFonden, Denmark; Slagelse Hospital; Region Zealand; Association of Danish Physiotherapists
Recruiting - Condition: Asthma
Interventions: Drug: Treatment A: Matching placebo (morning dose) and QVM149 150/50/80 μg (evening dose); Drug: Treatment B: QVM149 150/50/80 μg (morning dose) and matching placebo (evening dose); Drug: Treatment C: Placebo (morning dose) and placebo (evening dose)
Sponsor: Novartis Pharmaceuticals
Recruiting - Condition: Urticaria Chronic
Intervention: Drug: Omalizumab
Sponsors: Johns Hopkins University; National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - Condition: Immunity
Interventions: Other: Infant formula with added synbiotics; Other: Standard infant formula
Sponsor: Nutricia Research
Recruiting - Condition: Asthma, Allergic
Interventions: Drug: REGN3500; Drug: Dupilumab; Drug: Placebo; Drug: Fluticasone propionate
Sponsors: Regeneron Pharmaceuticals; Sanofi
Recruiting - Condition: Immunity
Interventions: Other: Infant Formula with added synbiotics; Other: Standard Infant formula
Sponsor: Nutricia Research
Not yet recruiting - Conditions: Asthma; Cough; Cough Variant Asthma
Interventions: Drug: Methacholine (MCh) Challenge Testing; Diagnostic Test: Eucapneic Voluntary Hyperventilation (EVH) and Hypertonic Saline (HS) Challenge Tests
Sponsor: Queen's University
Not yet recruiting - Condition: Eosinophilic Esophagitis
Intervention: Diagnostic Test: Plasma and urine metabolomics
Sponsors: The University of Texas Health Science Center, Houston; Baylor College of Medicine
Recruiting - Condition: Avian Hypersensitivity Pneumonitis
Interventions: Other: additional blood sample; Other: respiratory functional exploration
Sponsor: Centre Hospitalier Universitaire de Besancon
Recruiting - Condition: Amblyopia
Interventions: Drug: Donepezil; Behavioral: Single-letter training; Behavioral: Uncrowd training
Sponsor: Dennis Levi
Recruiting - Condition: LRTI
Intervention: Device: PCT Arm
Sponsor: Johns Hopkins University
Recruiting - Conditions: Insulin Sensitivity; Fat; Liver
Intervention:
Sponsor: University of Alabama at Birmingham
Recruiting - Conditions: Metabolic Syndrome; Physical Activity; Insulin Resistance; Cardiovascular Diseases
Intervention: Behavioral: Reduced sitting
Sponsors: Turku University Hospital; UKK Institute
Recruiting - Condition: Myocardial Infarction
Intervention:
Sponsor: University Hospital Southampton NHS Foundation Trust
Not yet recruiting - Condition: Nasal Allergy
Interventions: Procedure: Nasal lavage; Procedure: Nasal allergen challenge; Procedure: Epicutaneous skin testing; Procedure: Peripheral blood; Drug: Montelukast 10Mg Tablet; Drug: Placebo Oral Tablet
Sponsors: Mitchell Grayson; National Heart, Lung, and Blood Institute (NHLBI)
Recruiting - Condition: Lymphoma
Intervention: Drug: Revlimid
Sponsor: Celgene
Recruiting - Condition: Posttraumatic Stress Disorder
Interventions: Biological: Typhoid Vi Polysaccharide Vaccine; Biological: Placebo
Sponsors: University of California, San Francisco; National Institute of Mental Health (NIMH)
Not yet recruiting - Condition: Asthma
Interventions: Diagnostic Test: Magnetic Resonance Imaging (MRI) with Ultrashort Echo Time (UTE); Diagnostic Test: Computed tomography (CT)
Sponsor: University Hospital, Bordeaux
Recruiting - Condition: Atopic Dermatitis Eczema
Intervention: Other: electronic-Patient Report Outcome and wear of a wristband actigraph
Sponsor: Ad scientiam
Recruiting - Condition: Non-celiac Wheat Sensitivity
Intervention: Other: Gluten free diet
Sponsor: University of Palermo
Recruiting - Condition: Dermatitis, Atopic
Intervention: Device: Full Body Blue Light Device
Sponsors: Philips Light and Health; University Hospital Goettingen; Philipps University Marburg Medical Center; University Hospital, Geneva
Recruiting - Condition: Atopic Dermatitis
Intervention: Other: Narrow band UVB treatment (NB-UVB)
Sponsor: Rockefeller University
Recruiting - Condition: Non-celiac Wheat Sensitivity
Interventions: Dietary Supplement: Wheat flour; Dietary Supplement: Placebo
Sponsor: University of Palermo
Recruiting - Condition: Non-celiac Wheat Sensitivity
Intervention: Other: Gluten free diet
Sponsor: University of Palermo
Not yet recruiting - Conditions: Healthy Subjects; Pre-diabetes
Interventions: Dietary Supplement: Raspberry and fructooligosaccharide; Dietary Supplement: Raspberry
Sponsor: Institute for Food Safety and Health, United States
Recruiting - Condition: Diabetes Mellitus
Intervention: Other: individualized insulin sensitivity index (ISind)
Sponsor: Yale University
Not yet recruiting - Condition: Eosinophilic Esophagitis
Intervention: Device: swallowed sponge device
Sponsor: Mayo Clinic
Recruiting - Condition: Peanut Allergy
Intervention: Other: Peanut in diet
Sponsors: Johns Hopkins University; National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - Condition: Allergic Rhinitis
Intervention: Other: Self Questionnaire
Sponsor: University Hospital, Montpellier
Recruiting - Conditions: Insulin Sensitivity; Insulin Resistance; Type 2 Diabetes Mellitus
Intervention: Dietary Supplement: Yakult light
Sponsors: Loughborough University; Yakult Honsha Co., LTD
Recruiting - Condition: Colon Carcinoma
Interventions: Drug: Nivolumab; Drug: Ipilimumab; Drug: Celecoxib 200mg
Sponsors: The Netherlands Cancer Institute; Bristol-Myers Squibb
Recruiting - Condition: Non-celiac Wheat Sensitivity
Interventions: Other: Lactose breath test; Other: DBPC cow's milk protein challenge
Sponsor: University of Palermo
Recruiting - Conditions: Insulin Sensitivity; Oxidative Stress
Interventions: Drug: Galantamine; Drug: Placebo
Sponsor: Vanderbilt University Medical Center
Recruiting - Condition: Asthma
Interventions: Drug: QVM149 150/50/80 μg o.d.; Drug: QVM149 150/50/160 μg o.d.; Drug: salmeterol/fluticasone FDC 50/500 μg b.i.d.
Sponsor: Novartis Pharmaceuticals
Recruiting - Conditions: Retinoblastoma; Cataracts Infantile; Glaucoma, Congenital; Leucocoria
Interventions: Other: CRADLE; Other: Red reflex testing
Sponsor: St. Jude Children's Research Hospital
Recruiting - Conditions: Asthma; Chronic Obstructive Pulmonary Disease
Intervention: Device: The Inflammacheck Device
Sponsors: Portsmouth Hospitals NHS Trust; Asthma UK
Recruiting - Conditions: Physical Inactivity; Dietary Protein
Intervention: Behavioral: activity level
Sponsors: University of Missouri-Columbia; American Egg Board
Recruiting - Condition: Moderate-to-severe Atopic Dermatitis
Intervention: Other: No study intervention
Sponsor: Technische Universität Dresden
Recruiting - Condition: Asthma
Interventions: Drug: QAW039 Dose 1; Drug: QAW039 Dose 2; Drug: Placebo
Sponsor: Novartis Pharmaceuticals
Recruiting - Condition: Asthma
Interventions: Drug: C1-inhibitor; Other: Saline; Drug: Antibiotics
Sponsors: T. van der Poll; ZonMw: The Netherlands Organisation for Health Research and Development; Sanquin
Recruiting - Condition: Severe Atopic Dermatitis
Interventions: Other: Polyethylene glycol hexadecyl ether & Betamethasone valerate cream 0.1%; Other: Fusidic acid, polyethylene glycol hexadecyl ether & Betamethasone valerate cream 0.1%
Sponsor: Red Cross War Memorial Childrens Hospital
Not yet recruiting - Condition: Peanut Allergy
Intervention: Biological: AR101
Sponsor: Aimmune Therapeutics, Inc.
Recruiting - Conditions: Atopic Dermatitis; Ichthyosis; Psoriasis
Interventions: Other: Itch Questionnaire and Interview; Other: Stigma Questionnaire and Interview; Other: Cognitive Interview and PROMIS Itch Questionnaire
Sponsor: Northwestern University
Recruiting - Condition: Peanut Allergy
Interventions: Biological: HAL-MPE1; Drug: HAL-MPE1 placebo
Sponsor: HAL Allergy
Recruiting - Condition: Asthma in Children
Intervention:
Sponsors: Beijing Children's Hospital; Shengjing Hospital; Capital Institute of Pediatrics, China; Xinhua Hospital, Shanghai Jiao Tong University School of Medicine; China-Japan Friendship Hospital; Ruijin Hospital; Xiangya Hospital of Central South University; Beijing Chao Yang Hospital
Not yet recruiting - Condition: Soft Tissue Sarcoma Adult
Interventions: Drug: Multiple drug microinjection; Device: CIVO device
Sponsors: Presage Biosciences; Fred Hutchinson Cancer Research Center; University of Washington; Northwell Health
Recruiting - Condition: Effect of Magnesium in Diabetes
Interventions: Dietary Supplement: Magnesium citrate; Dietary Supplement: Placebo
Sponsor: Protina Pharmazeutische GmbH
Recruiting - Condition: Asthma
Intervention: Drug: Budesonide
Sponsor: Bispebjerg Hospital
Recruiting - Condition: Allergic Rhinitis
Interventions: Drug: Bu-Zhong-Yi-Qi-Tang; Drug: placebo
Sponsor: Chang Gung Memorial Hospital
Recruiting - Conditions: ASTHMA; ANXIETY
Intervention: Behavioral: heart rate variability biofeedback
Sponsor: Rutgers, The State University of New Jersey
Not yet recruiting - Condition: Asthma, Aspirin-Induced
Interventions: Drug: Ifetroban Oral Capsule; Drug: Placebo Oral Capsule
Sponsor: Cumberland Pharmaceuticals
Recruiting - Conditions: Platinum Sensitive Ovarian Cancer; Ovarian Cancer
Interventions: Biological: FRα peptide plus Adjuvant (GM-CSF); Drug: Adjuvant (GM-CSF) Alone
Sponsor: Tapimmune Inc.
Recruiting - Condition: Relapsed Ovarian Cancer, BRCA Mutation, Platinum Sensitivity
Intervention: Drug: OLAPARIB
Sponsor: AstraZeneca
Recruiting - Conditions: Insulin Sensitivity; Metabolism Disorder
Intervention: Other: Stabile Isotope tracers
Sponsor: University Hospital, Gentofte, Copenhagen
Recruiting - Conditions: Hereditary AngioEdema; Angioedema, Hereditary; Angio-Oedema of Lips; Angio-Oedema of Tongue
Intervention:
Sponsors: University of Rostock; Centogene AG Rostock
Recruiting - Conditions: Acute Coronary Syndrome; Chest Pain
Interventions: Procedure: Blood Sample; Behavioral: HEART Score
Sponsors: University of Florida; Roche Diagnostics
Recruiting - Conditions: Asthma; Healthy
Intervention: Other: Assessment of E-nose measurements
Sponsors: Istituto di Biomedicina e Immunologia Molecolare Alberto Monroy; Campus Bio-Medico University
Recruiting - Condition: Inflammatory Back Pain
Intervention: Other: Gluten free diet
Sponsor: University of Palermo
Not yet recruiting - Conditions: Insulin Sensitivity; Obesity; Sedentary Lifestyle
Intervention: Behavioral: Exercise
Sponsor: Oregon State University
Recruiting - Condition: Hemoperitoneum
Intervention: Procedure: Fast exam
Sponsor: The Guthrie Clinic
Recruiting - Condition: Atopic Dermatitis
Intervention: Biological: Roseomonas mucosa
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - Conditions: Asthma; Gastroesophageal Reflux
Interventions: Drug: commercially available lansoprazole; Drug: matched placebo
Sponsors: Jason Lang, M.D., M.P.H.; Thrasher Research Fund; Nemours Children's Clinic
Recruiting - Conditions: Sinusitis; Asthma
Interventions: Drug: Mometasone Nasal; Drug: placebo mometasone
Sponsor: Medical Universtity of Lodz
Recruiting - Condition: Peanut Allergy
Intervention: Biological: Fecal Microbiota Capsule
Sponsor: Rima Rachid
Recruiting - Conditions: Type2 Diabetes; Weight Loss; Insulin Sensitivity; Metabolism and Nutrition Disorder; Metabolism Disorder, Glucose; Bariatric Surgery Candidate
Interventions: Procedure: Gastric by-pass surgery; Dietary Supplement: Low-caloric diet
Sponsors: Uppsala University; AstraZeneca
Recruiting - Condition: Interstitial Lung Disease
Interventions: Drug: Pirfenidone; Other: Placebo controlled
Sponsors: National Jewish Health; Genentech, Inc.
Recruiting - Conditions: Type 1 Diabetes Mellitus; Maturity-Onset Diabetes of the Young, Type 2; MODY2; Insulin Resistance
Interventions: Drug: Hyperinsulinemic, euglycemic clamp; Drug: 20% dextrose
Sponsor: Vanderbilt University
Recruiting - Conditions: Insulin Sensitivity; Type2 Diabetes
Interventions: Behavioral: Increased dairy product; Behavioral: Dietary counselling
Sponsors: CHU de Quebec-Universite Laval; Canadian Institutes of Health Research (CIHR)
Recruiting - Condition: Tuberculosis
Interventions: Drug: Everolimus 0.5 MG; Drug: Auranofin 6 MG; Drug: Vitamin D3; Drug: CC-11050; Drug: 2HRbZE/4HRb
Sponsor: The Aurum Institute NPC
Recruiting - Condition: Atopic Dermatitis
Interventions: Drug: SAN007 Cream; Drug: Placebo
Sponsors: Santalis Pharmaceuticals, Inc.; ClinDatrix, Inc.; Fremantle Dermatology
Not yet recruiting - Conditions: Asthma, Allergic; Rhinitis,Allergic; Allergy
Interventions: Drug: Azelastine-Fluticasone Nasal; Drug: Placebos
Sponsor: University of Dundee
Recruiting - Condition: Asthma
Intervention: Drug: PARTICS using QVAR
Sponsors: Brigham and Women's Hospital; Patient-Centered Outcomes Research Institute; American Academy of Family Physicians
Recruiting - Conditions: Eosinophilic Esophagitis; Healthy
Intervention: Device: Mucosal Impedance Balloon catheter
Sponsors: Mayo Clinic; Sandhill Scientific
Recruiting - Condition: Asthma
Intervention: Device: anharmonic morphological analysis of the respiratory signals (AMARS)
Sponsor: University Hospital, Bordeaux
Recruiting - Conditions: Cow's Milk Protein Allergy; Eosinophilic Gastrointestinal Disorders; Malabsorption/Maldigestion; Short Bowel Syndrome; Multiple Food Allergies
Intervention: Other: Free amino acid infant formula
Sponsor: Nestlé
Recruiting - Condition: Rhinitis, Allergic, Perennial
Interventions: Drug: Budesonid 50mcg (Noex); Drug: Budesonid 50mcg (Busonid)
Sponsor: Eurofarma Laboratorios S.A.
Not yet recruiting - Conditions: Overweight; Obesity; Insulin Resistance
Interventions: Other: Plant-based diet; Other: Control Diet
Sponsors: Physicians Committee for Responsible Medicine; Yale University
Recruiting - Condition: Asthma
Interventions: Device: TURBUHALER®; Device: SPIROMAX®
Sponsor: Fundación Pública Andaluza Progreso y Salud
Recruiting - Condition: Asthma
Interventions: Drug: Fp MDPI; Drug: FS MDPI; Drug: Placebo
Sponsor: Teva Branded Pharmaceutical Products, R&D Inc.
Recruiting - Conditions: BRCA1 Gene Mutation; BRCA2 Gene Mutation; Ovarian Serous Adenocarcinoma; Recurrent Fallopian Tube Carcinoma; Recurrent Ovarian Carcinoma; Recurrent Primary Peritoneal Carcinoma
Interventions: Biological: Durvalumab; Other: Laboratory Biomarker Analysis; Drug: Olaparib; Biological: Tremelimumab
Sponsors: Roswell Park Cancer Institute; National Cancer Institute (NCI)
Recruiting - Conditions: Spinal Deformity; Spinal Fractures; Spinal Injuries; Kyphosis
Intervention: Other: Retrospective radiological evaluation
Sponsor: AO Clinical Investigation and Documentation
Recruiting - Condition: Peanut Allergy
Interventions: Drug: ANB020; Drug: Placebo
Sponsor: AnaptysBio, Inc.
Recruiting - Conditions: Cirrhosis; Food Preferences; Taste Disorders; Protein-Energy Malnutrition; Chronic Renal Failure
Intervention:
Sponsor: University of Burgundy
Recruiting - Condition: Rhinitis, Allergic, Perennial
Intervention: Drug: Budesonide
Sponsor: Eurofarma Laboratorios S.A.
Not yet recruiting - Condition: Status Asthmaticus
Intervention: Drug: preservative free albuterol
Sponsors: University of Louisville; Norton Healthcare
Not yet recruiting - Condition: Idiopathic Angioedema
Interventions: Drug: Omalizumab; Drug: Placebos
Sponsors: University of Wisconsin, Madison; Novartis Pharmaceuticals
Recruiting - Conditions: Aortitis; Cutaneous Vasculitis; Eosinophilic Granulomatosis With Polyangiitis; Giant Cell Arteritis; Granulomatosis With Polyangiitis (Wegener's); Henoch-Schonlein Purpura; IgA Vasculitis; Microscopic Polyangiitis; Polyarteritis Nodosa; Takayasu Arteritis; Churg-Strauss Syndrome
Intervention:
Sponsors: University of Pennsylvania; National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS); National Center for Advancing Translational Science (NCATS); Office of Rare Diseases (ORD)
Recruiting - Condition: Allergic Rhinitis
Interventions: Drug: EMS Mometasone gel; Drug: Mometasone spray nasal
Sponsor: EMS
Not yet recruiting - Condition: Allergic Rhinitis
Interventions: Drug: EMS Mometasone gel; Drug: Mometasone spray nasal
Sponsor: EMS
Not yet recruiting - Conditions: Moderate Persistent Asthma; Severe Persistent Asthma; Nodule Solitary Pulmonary; Pulmonary Atelectasis
Intervention: Procedure: Bronchial biopsy
Sponsor: Lu Yuan Lee
Not yet recruiting - Condition: Asthma
Interventions: Drug: Dupilumab; Other: Placebo; Drug: Asthma Controller Therapies (incl. prednisone/prednisolone); Drug: Asthma Reliever Therapies
Sponsors: Sanofi; Regeneron Pharmaceuticals
Recruiting - Conditions: Food Allergy Suspected; Food Allergy Proved
Intervention: Other: Pulmonary function test
Sponsor: University Hospital, Montpellier
Recruiting - Conditions: Obese; Metabolic Syndrome
Interventions: Drug: Mirabegron; Drug: Pioglitazone; Drug: Mirabegron and Pioglitazone
Sponsors: Philip Kern; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Recruiting - Condition: Acute Urticaria
Interventions: Drug: Test Drug (JDP-205); Drug: Active Control (Diphenhydramine)
Sponsor: JDP Therapeutics, Inc.
Recruiting - Condition: Asthma
Intervention: Dietary Supplement: L-Citrulline
Sponsor: University of Colorado, Denver
Recruiting - Condition: Food Allergy
Interventions: Drug: Chinese Herbal Medication; Drug: Placebo; Drug: Omalizumab; Drug: Multi OIT
Sponsor: Xiu-Min Li
Recruiting - Condition: Apnea, Sleep
Intervention: Drug: Targeted infusion of remifentanil
Sponsor: Washington University School of Medicine
Recruiting - Condition: Macular Hole Surgery
Intervention:
Sponsor: Fondation Ophtalmologique Adolphe de Rothschild
Recruiting - Conditions: Insulin Sensitivity; Glucose Tolerance; Sedentary Behaviour; Physical Activity
Interventions: Behavioral: Sit-stand desk; Behavioral: Sitting desk
Sponsor: University of Prince Edward Island
Recruiting - Condition: Pediatrics
Interventions: Behavioral: collection data; Behavioral: IRM
Sponsor: University Hospital, Strasbourg, France
Recruiting - Condition: Bronchial Asthma
Interventions: Drug: Ke Chuan Liu Wei Mixture; Drug: Chuan Xiong Ping Chuan Mixture; Drug: Xie Wu Capsule; Drug: Dan Ma Jia Tablet; Drug: Zhi Chuan Capsule; Drug: Bu Shen Na Qi Granule; Drug: Ke Chuan Liu Wei Mixture placebo; Drug: Chuan Xiong Ping Chuan Mixture placebo; Drug: Xie Wu Capsule placebo; Drug: Dan Ma Jia Tablet placebo; Drug: Zhi Chuan Capsule placebo; Drug: Bu Shen Na Qi Granule placebo
Sponsor: Shanghai University of Traditional Chinese Medicine
Not yet recruiting - Condition: Childhood Asthma With Status Asthmaticus
Intervention:
Sponsors: Erasmus Medical Center; Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA); Radboud University; Maasstad Hospital; VU University Medical Center; UMC Utrecht; University Medical Center Groningen; Amphia Hospital; Rijnstate Hospital; Tergooi Hospital; Maastricht University Medical Center; Leiden University Medical Center
Recruiting - Condition: Asthma
Interventions: Drug: Reslizumab; Drug: Fludeoxyglucose F 18 (FDG); Drug: Placebo
Sponsor: Teva Branded Pharmaceutical Products, R&D Inc.
Recruiting - Condition: Rhinitis,Allergic
Interventions: Dietary Supplement: Broccoli Sprout Extract; Drug: fluticasone nasal; Dietary Supplement: brocooli sprout extract placebo; Drug: normal saline nasal spray
Sponsor: VA Office of Research and Development
Recruiting - Condition: Multiple Sclerosis
Intervention:
Sponsor: Fondation Ophtalmologique Adolphe de Rothschild
Recruiting - Conditions: Primary Cutaneous Vasculitis; Cutaneous Polyarteritis Nodosa; IgA Vasculitis; Henoch-Schönlein Purpura
Interventions: Drug: Colchicine; Drug: Dapsone; Drug: Azathioprine
Sponsors: University of Pennsylvania; National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS); National Center for Advancing Translational Science (NCATS); Office of Rare Diseases (ORD)
Recruiting - Conditions: B Acute Lymphoblastic Leukemia; Central Nervous System Leukemia; Ph-Like Acute Lymphoblastic Leukemia; Testicular Leukemia; Untreated Adult Acute Lymphoblastic Leukemia; Untreated Childhood Acute Lymphoblastic Leukemia
Interventions: Drug: Clofarabine; Drug: Cyclophosphamide; Drug: Cytarabine; Drug: Dasatinib; Drug: Dexamethasone; Drug: Doxorubicin Hydrochloride; Drug: Etoposide; Drug: Hydrocortisone Sodium Succinate; Other: Laboratory Biomarker Analysis; Drug: Leucovorin Calcium; Drug: Mercaptopurine; Drug: Methotrexate; Drug: Pegaspargase; Drug: Prednisone; Radiation: Radiation Therapy; Drug: Thioguanine; Drug: Vincristine Sulfate
Sponsor: National Cancer Institute (NCI)
Recruiting - Conditions: Obesity; Insulin Resistance; Sedentary Lifestyle
Interventions: Behavioral: Moderate intensity exercise training (MOD-INT); Behavioral: High Intensity exercise training (HI-INT)
Sponsor: East Carolina University
Recruiting - Condition: Prostate Cancer
Interventions: Radiation: Radiotherapy to the pelvis; Drug: Hormonal therapy (LHRH agonist and/or antiandrogens)
Sponsor: University Hospital "Sestre Milosrdnice"
Recruiting - Condition: Asthma
Interventions: Drug: FF/UMEC/VI (100/31.25/25) mcg; Drug: FF/UMEC/VI (100/62.5/25) mcg; Drug: FF/UMEC/VI (200/31.25/25) mcg; Drug: FF/UMEC/VI (200/62.5/25) mcg; Drug: FF/VI (100/25) mcg; Drug: FF/VI (200/25) mcg; Drug: Fluticasone/salmeterol (FSC); Drug: Albuterol/salbutamol; Device: ELLIPTA DPI; Device: DISKUS DPI; Device: METERED-DOSE INHALER (MDI)
Sponsor: GlaxoSmithKline
Recruiting - Condition: Atopic Dermatitis
Interventions: Drug: DS107; Other: Vehicle cream
Sponsor: DS Biopharma
Recruiting - Conditions: Atopic Dermatitis; Vascular Inflammation; Coronary Atherosclerosis
Interventions: Other: FDG-PET Scan; Other: MDCT; Other: biopsy and blood collection
Sponsors: Innovaderm Research Inc.; Montreal Heart Institute; Icahn School of Medicine at Mount Sinai
Recruiting - Condition: Peanut Allergy
Interventions: Drug: ASP0892 Intradermal; Drug: ASP0892 Intramuscular; Drug: Placebo Intradermal; Drug: Placebo Intramuscular
Sponsor: Astellas Pharma Global Development, Inc.
Recruiting - Conditions: Phobias; Claustrophobia; Social Phobia
Interventions: Behavioral: Extinction Training; Device: Low-Level Laser Therapy; Device: Sham Low-Level Laser Therapy
Sponsor: University of Texas at Austin
Recruiting - Conditions: Lung Neoplasms; Carcinoma, Non-Small-Cell Lung; Neoplasms; Lung Diseases; Adenocarcinoma; Advanced Solid Tumors
Intervention: Drug: CK-101
Sponsor: Checkpoint Therapeutics, Inc.
Recruiting - Condition: Atopic Eczema
Intervention: Radiation: combined ultraviolet phototherapy (NB-UVB + UVA1) vs. NB-UVB monotherapy
Sponsors: University of Dundee; NHS Tayside
Recruiting - Condition: Asthma
Intervention: Behavioral: Electronic sensor and OW education
Sponsors: Montefiore Medical Center; Stony Wold-Herbert Fund, Inc.
Recruiting - Conditions: Asthma; Allergic Rhinitis
Intervention: Biological: Rhinovirus (GMP RV16 HRV-16)
Sponsors: University of Virginia; National Institutes of Health (NIH); National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - Conditions: Invasive Cancer; Ductal Carcinoma in Situ
Interventions: Device: Ultrasonography; Device: Digital mammography
Sponsors: Soonchunhyang University Hospital; Ministry of Health & Welfare, Korea
Recruiting - Condition: Dermatitis, Atopic
Intervention: Drug: Nanodox 1% (doxycycline monohydrate hydrogel)
Sponsors: University of Florida; Alchem Laboratories, Inc
Recruiting - Condition: Insulin Secretion
Interventions: Drug: intranasal insulin; Drug: Placebo
Sponsor: University Hospital Tuebingen
Recruiting - Condition: Neuropathic Pain
Interventions: Other: stimulation on painful area (area allodynic); Other: same stimulation on non-painful area; Radiation: MRI scan
Sponsor: Centre Hospitalier Universitaire de Saint Etienne
Recruiting - Condition: Dermatitis, Atopic
Intervention: Other: standardized skin care regimen
Sponsors: HiPP GmbH & Co. Vertrieb KG; Charite University, Berlin, Germany
Recruiting - Condition: Lung Neoplasms
Intervention:
Sponsors: Wissenschaftliches Institut Bethanien e.V; Merck Sharp & Dohme Corp.; Institute of Pathology, University Clinic Düsseldorf
Recruiting - Condition: Ovarian Cancer
Interventions: Drug: Olaparib; Drug: Cediranib; Drug: Platinum-based Chemotherapy
Sponsor: Rozalia Lubiatowska
Recruiting - Condition: Mild Asthma
Interventions: Drug: QMF149 150/80 μg; Drug: MF 200 μg
Sponsor: Novartis Pharmaceuticals
Recruiting - Condition: Asthma
Interventions: Drug: Indacaterol acetate 75 μg; Drug: Indacaterol acetate 150 μg
Sponsor: Novartis Pharmaceuticals
Recruiting - Condition: Asthma
Interventions: Drug: Fluticasone furoate; Drug: Placebo; Drug: Montelukast; Drug: Short Acting Beta 2 Agonist
Sponsor: GlaxoSmithKline
Recruiting - Conditions: Asthma; Healthy
Intervention:
Sponsors: University of Michigan; National Institutes of Health (NIH)
Recruiting - Condition: Persistent Asthma
Intervention: Procedure: Bronchoscopy
Sponsors: University of Leicester; Genentech, Inc.; Queen's University, Belfast; Medical Research Council
Recruiting - Condition: Eosinophilic Esophagitis
Intervention: Other: Oral food desensitization
Sponsor: The University of Texas Health Science Center, Houston
Recruiting - Conditions: Asthmatic Crisis; Wheezing
Intervention: Dietary Supplement: Fultium-D3 drops (Internis)
Sponsor: Queen Mary University of London
Recruiting - Condition: First Manifestation of Steroid Sensitive Nephrotic Syndrome
Interventions: Drug: Levamisole Hydrochloride; Other: Placebo
Sponsor: Assistance Publique - Hôpitaux de Paris
Not yet recruiting - Condition: Status Asthmaticus
Interventions: Drug: Ipratropium; Drug: 0.9% Sodium Chloride; Drug: Albuterol; Drug: corticosteroids
Sponsor: University Hospitals Cleveland Medical Center
Recruiting - Condition: Asthma
Intervention: Device: Targeted Lung Denervation (TLD)
Sponsor: Nuvaira, Inc.
Recruiting - Conditions: Exercised Induced Asthma; Asthma
Interventions: Dietary Supplement: HOST-DM059; Dietary Supplement: Maltodextrin
Sponsors: Nottingham Trent University; University of Reading; Clasado Biosciences; Imperial College London; HOST Therabiomics; The John van Geest Cancer Research Centre
Recruiting - Condition: Asthma
Interventions: Other: Digital action plan for asthma exacerbations + Written action plan; Other: Written action plan
Sponsor: Assistance Publique - Hôpitaux de Paris
Recruiting - Condition: Eosinophilic Esophagitis
Interventions: Drug: EMS Fluticasone 1; Drug: EMS Fluticasone 2; Drug: EMS Fluticasone 3; Other: EMS Placebo Fluticasone
Sponsor: EMS
Not yet recruiting - Condition: Bronchial Diseases
Interventions: Drug: ACT guided Routine Treatment; Drug: Routine Treatment
Sponsors: GlaxoSmithKline; Macrostat
Recruiting - Conditions: Atopic Dermatitis; Eczema
Interventions: Drug: SAN007 5% cream; Drug: Placebo; Drug: SAN007 10% cream
Sponsors: Santalis Pharmaceuticals, Inc.; ClinDatrix, Inc.; Texas Dermatology and Laser Specialists; Clinical Trials of Texas, Inc; DermResearch, Inc; Progressive Clinical Research
Recruiting - Condition: Prostate Cancer Metastatic
Interventions: Drug: Enzalutamide; Procedure: 11C or 18F-Choline PET/CT; Procedure: Whole body MRI; Procedure: Bone scan
Sponsors: The European Uro-Oncology Group; Centre for Human Drug Research, Netherlands
Recruiting - Condition: Atopic Dermatitis
Interventions: Drug: DS107; Drug: Placebo
Sponsor: DS Biopharma
Recruiting - ODM-201 in Addition to Standard ADT and Docetaxel in Metastatic Castration Sensitive Prostate CancerCondition: Prostatic Neoplasms
Interventions: Drug: BAY1841788 / darolutamide (ODM-201); Drug: Standard ADT (androgen deprivation therapy); Drug: Docetaxel; Drug: Placebo
Sponsors: Bayer; Orion Corporation, Orion Pharma
Recruiting - Condition: Asthma
Intervention: Drug: Busonid (budesonide 200mcg and 400mcg)
Sponsor: Ache Laboratorios Farmaceuticos S.A.
Not yet recruiting - Conditions: Ovarian Cancer; Epithelial Ovarian Cancer; Fallopian Tube Cancer; Peritoneal Cancer
Interventions: Drug: Chemotherapy; Drug: Rucaparib
Sponsors: Clovis Oncology, Inc.; Foundation Medicine
Recruiting - Conditions: Hereditary Angioedema; Healthy Volunteers
Intervention: Other: blood sample
Sponsor: University Hospital, Grenoble
Recruiting - Condition: Depressed
Intervention:
Sponsors: Dr. Kate Harkness; University Health Network, Toronto; University of Calgary; Harvard University; McGill University
Recruiting - Condition: Oral Immunotherapy for Food Allergy
Intervention:
Sponsor: Assaf-Harofeh Medical Center
Recruiting - Conditions: Urticaria; Autoimmune Diseases; Immune System Diseases; Skin Diseases
Intervention: Biological: Autologous mesenchymal stem cell
Sponsors: Celal Bayar University; The Scientific and Technological Research Council of Turkey; Acıbadem Labcell
Recruiting - Condition: Asthma, Aspirin-Induced
Intervention: Drug: aspirin
Sponsor: Brigham and Women's Hospital
Recruiting - Conditions: Asthma; Allergic Rhinitis; Cystic Fibrosis; Pneumonia
Intervention:
Sponsor: Boston Children’s Hospital
Recruiting - Condition: Chronic Idiopathic Urticaria
Intervention: Biological: Xolair
Sponsors: William Henderson; University of Washington
Recruiting - Condition: Asthma
Interventions: Behavioral: Lifestyle Factors; Other: Customized use of Dietary Supplements; Other: Currently Accepted Asthma Care Guidelines
Sponsor: The Cleveland Clinic
Recruiting - Condition: Diabetes, Gestational
Intervention:
Sponsor: University of Aarhus
Recruiting - Conditions: Myelodysplastic Syndrome (MDS); Chronic Lymphocytic Leukemia (CLL); Chemotherapy-sensitive Lymphoma; Acute Lymphoblastic Leukemia (ALL)/T Lymphoblastic Lymphoma; Acute Myelogenous Leukemia (AML); Acute Biphenotypic Leukemia (ABL); Acute Undifferentiated Leukemia (AUL)
Interventions: Drug: Fludarabine; Drug: Cyclophosphamide 14.5 mg/kg/day IV on Days -6, -5; Radiation: Total Body Irradiation (TBI) 200cGy on Day -1; Procedure: Infusion of non-T-cell depleted bone marrow on Day 0; Drug: Busulfan; Drug: Cyclophosphamide 50mg/kg/day IV on Days -2,-1; Drug: Cyclophosphamide 50mg/kg/day IV on Days -5,-4; Radiation: Total Body Irradiation (TBI) 200cGy twice a day on Days -3, -2, -1; Drug: Post-HCT Cyclophosphamide 50mg/kg IV on Day+3, +4; Drug: Sirolimus; Drug: Mycophenolate mofetil; Drug: G-CSF; Drug: Pre-HCT Mesna on Days -6 and -5; Drug: Pre-HCT Mesna on Days -2 and -1; Drug: Pre-HCT Mesna on Days -5 and -4; Drug: Post-HCT Mesna
Sponsors: Center for International Blood and Marrow Transplant Research; National Marrow Donor Program; Resource for Clinical Investigation in Blood and Marrow Transplantation
Recruiting - Condition: Untreated Adult Acute Myeloid Leukemia
Interventions: Drug: Cytarabine; Drug: Dasatinib; Drug: Idarubicin; Other: Laboratory Biomarker Analysis; Drug: Nilotinib; Drug: Ponatinib Hydrochloride; Drug: Sorafenib Tosylate; Drug: Sunitinib Malate
Sponsors: OHSU Knight Cancer Institute; National Cancer Institute (NCI)
Recruiting - Conditions: Allergic Rhinitis; Peanut Allergies
Intervention:
Sponsor: Queen's University
Recruiting - Condition: Asthma
Intervention: Other: Not an interventional study
Sponsor: Boston Children’s Hospital
Recruiting - Condition: Metastatic Renal Cell Carcinoma
Intervention:
Sponsors: Pfizer; TFS Trial Form Support
Recruiting - Conditions: Eosinophilic Gastrointestinal Disorders (EGIDs); Eosinophilic Esophagitis (EoE)
Interventions: Other: elimination diet therapy; Drug: Flovent
Sponsors: Children's Hospital Medical Center, Cincinnati; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); National Institute of Allergy and Infectious Diseases (NIAID); Office of Rare Diseases (ORD); National Center for Advancing Translational Science (NCATS)
Recruiting - Condition: Asthma
Intervention:
Sponsor: University of Texas Southwestern Medical Center
Recruiting - Conditions: Lung Transplant; Lung Resection; Lung Cancer; Asthma; Cystic Fibrosis; Chronic Obstructive Pulmonary Disease; Emphysema; Mesothelioma; Asbestosis; Pulmonary Embolism; Interstitial Lung Disease; Pulmonary Fibrosis; Bronchiectasis; Seasonal Allergies; Cold Virus; Lung Infection; Pulmonary Hypertension; Pulmonary Dysplasia; Obstructive Sleep Apnea
Interventions: Drug: HP 3He; Drug: HP 129Xe; Drug: PFP; Drug: SF6; Device: 129Xe Small and Large Human Lung Coil; Device: 3He Human Lung Coil; Device: PFP and SF6 Human Lung Coil
Sponsors: Thunder Bay Regional Research Institute; Thunder Bay Regional Health Sciences Centre; St. Joseph's Care Group; Lakehead University
Not yet recruiting - Condition: Eosinophilic Esophagitis
Intervention: Other: Observation Period
Sponsors: University of Wisconsin, Madison; National Institutes of Health (NIH); National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - Condition: Gestational Diabetes Mellitus
Intervention: Other: Oral glucose tolerance test
Sponsor: Massachusetts General Hospital
Recruiting - Conditions: Asthma; COPD; Chronic Obstructive Pulmonary Disease
Interventions: Procedure: Blood draw; Procedure: Urine; Procedure: Lung function measurements; Procedure: Fractional Exhaled Nitric Oxide (FENO)
Sponsors: AstraZeneca; Parexel
Recruiting - Condition: Asthma
Interventions: Device: Active Air Purifier; Device: Placebo Air Purifier
Sponsor: Johns Hopkins University
Recruiting - Condition: Asthma
Interventions: Genetic: Personalised medicine (Salmeterol); Genetic: Personalised medicine (Montelukast); Other: Standard care
Sponsor: University of Sussex
Recruiting - Conditions: Cardiac Arrest; Acute Coronary Lesion; Stable Obstructive Coronary Disease; Non-obstructive Coronary Disease
Intervention: Other: Blood sample collection
Sponsor: University Medical Centre Ljubljana
Recruiting - Condition: Asthma
Interventions: Other: TEAM-ED; Other: Enhanced Usual Care
Sponsor: University of Rochester
Recruiting - Conditions: Asthma; OSA
Intervention: Device: continuous positive airway pressure (CPAP)
Sponsors: Chang Gung Memorial Hospital; Ministry of Science and Technology, Taiwan
Recruiting - Conditions: Ovarian Cancer; Peritoneal Carcinomatosis; Fallopian Tube Cancer
Intervention: Biological: GL-ONC1
Sponsor: Genelux Corporation
Recruiting - Condition: Atopic Dermatitis
Interventions: Drug: PAC-14028 Cream 0.1%; Drug: PAC-14028 Cream 0.3%; Drug: PAC-14028 Cream 1.0%; Drug: PAC-14028 Cream Vehicle
Sponsor: Amorepacific Corporation
Recruiting - Conditions: Healthy; Chronic Rhinosinusitis With Nasal Polyps; Atopic Dermatitis
Interventions: Biological: PF-06817024; Other: Placebo for PF-06817024
Sponsor: Pfizer
Recruiting - Condition: Allergies
Interventions: Other: Phthalate; Other: Filtered Air; Other: Allergen
Sponsor: University of British Columbia
Recruiting - Condition: Asthma
Interventions: Drug: Fluticasone propionate HFA 220; Drug: Placebo
Sponsor: New York University School of Medicine
Recruiting - Condition: Impaired Glucose Tolerance
Interventions: Drug: Gymnema Sylvestre; Drug: Placebo
Sponsor: University of Guadalajara
Recruiting - Condition: Insulin Sensitivity
Interventions: Dietary Supplement: carnosine; Other: Placebo
Sponsor: Monash University
Recruiting - Condition: Asthma
Interventions: Device: Sensor cap system for inhalers; Other: App for SmartPhone; Behavioral: Motivational interviews; Other: Telehealth clinic visits
Sponsors: Children's Hospital Medical Center, Cincinnati; Verizon Foundation; Luther Foundation
Recruiting - Condition: Eosinophilic Esophagitis (EoE)
Interventions: Drug: Oral Budesonide Suspension (OBS); Drug: Placebo
Sponsor: Shire
Recruiting - Condition: Celiac Disease
Intervention:
Sponsor: Mayo Clinic
Recruiting - Conditions: Healthy; Obesity; Insulin Sensitivity; Women
Intervention:
Sponsors: University of Arkansas; Arkansas Children's Hospital Research Institute
Recruiting - Conditions: Cancer Prevention; Tobacco Use Cessation
Interventions: Behavioral: Questionnaires; Behavioral: CO Level Testing; Behavioral: Behavior Activation Treatment (BAT); Behavioral: Standard Cessation (SC); Drug: Nicotine Patch; Behavioral: Cotinine Level Testing; Procedure: Lab Session
Sponsors: M.D. Anderson Cancer Center; National Institute on Drug Abuse (NIDA)
Recruiting - Conditions: Pediatric Obesity; Obesity
Interventions: Behavioral: Healthy Caregivers- Healthy Children Toolkit; Behavioral: Safety Curriculum
Sponsor: University of Miami
Recruiting - Conditions: Colorectal Neoplasms; Colorectal Cancer; Breast Cancer; Breast Neoplasms; Ovarian Cancer; Ovarian Neoplasm
Intervention: Other: Molecular Profiling & In Vivo drug testing in pPDX and organoid cultures
Sponsor: University Health Network, Toronto
Recruiting - Condition: Non Small Cell Lung Cancer
Interventions: Drug: Olaparib; Drug: Placebo
Sponsor: Gustave Roussy, Cancer Campus, Grand Paris
Recruiting - Condition: Asthma
Interventions: Device: CREON2000A; Device: Sham
Sponsors: General Innovations and Goods, Inc.; National Institute of Allergy and Infectious Diseases (NIAID); University of Cincinnati; Bernstein Clinical Research Center
Recruiting - Condition: Headache Migraine Chronic
Interventions: Device: Gray tinted spectacle lenses; Device: Thin-Film spectacle lenses
Sponsors: University of Utah; Axon Optics, LLC; Mayo Clinic; Brigham and Women's Hospital; Northwell Health
Recruiting - Conditions: Asthma; Childhood Asthma
Interventions: Behavioral: PEF Feedback; Behavioral: Control Feedback
Sponsors: Albert Einstein College of Medicine, Inc.; National Heart, Lung, and Blood Institute (NHLBI)
Recruiting - Condition: Allergic Rhinitis
Interventions: Biological: ILIT with extract of causal allergen; Biological: ILIT with normal saline; Drug: Rescue medication for allergic rhinitis
Sponsors: Gachon University Gil Medical Center; Korea Research Foundation
Recruiting - Condition: Laparoscopic Abdominal Surgery
Interventions: Dietary Supplement: simple carbohydrate drink; Dietary Supplement: complex carbohydrate drink
Sponsors: McGill University Health Center; Mitacs; Medtronic - MITG
Recruiting - Conditions: Rhinitis; Rhinoconjunctivitis
Interventions: Biological: MM09 Mannosylated 5.000 subcutaneous; Biological: MM09 Mannosylated 10.000 subcutaneous; Biological: MM09 Mannosylated 30.000 subcutaneous; Biological: MM09 Mannosylated 50.000 subcutaneous; Biological: MM09 Mannosylated 5.000 sublingual; Biological: MM09 Mannosylated 10.000 sublingual; Biological: MM09 Mannosylated 30.000 sublingual; Biological: MM09 Mannosylated 50.000 sublingual; Biological: Subcutaneous placebo; Biological: Sublingual placebo
Sponsor: Inmunotek S.L.
Recruiting - Conditions: Sleep Initiation and Maintenance Disorders; Anxiety; Post-Traumatic Stress Disorder; Hot Flashes; Headache; Traumatic Brain Injury; Post Concussion Symptoms
Intervention: Device: HIRREM
Sponsor: Wake Forest University Health Sciences
Recruiting - Conditions: Rhinitis; Rhinoconjunctivitis
Interventions: Biological: MG56 Mannosylated 60 subcutaneous; Biological: MG56 Mannosylated 100 subcutaneous; Biological: MG56 Mannosylated 300 subcutaneous; Biological: MG56 Mannosylated 500 subcutaneous; Biological: MG56 Mannosylated 60 sublingual; Biological: MG56 Mannosylated 100 sublingual; Biological: MG56 Mannosylated 300 sublingual; Biological: MG56 Mannosylated 500 sublingual; Biological: Subcutaneous placebo; Biological: Sublingual placebo
Sponsor: Inmunotek S.L.
Recruiting - Condition: Myocardial Infarction
Intervention: Procedure: Accelerated, combined biomarker rule-out strategy for MI
Sponsor: Aarhus University Hospital Skejby
Recruiting - Condition: Asthma
Intervention: Other: Exercise program
Sponsor: Universidad Europea de Madrid
Recruiting - Condition: Psoriasis
Interventions: Other: Acetylcholine iontophoresis; Other: Sodium Nitroprussiate iontophoresis; Other: ppi water iontophoresis; Other: Laser Doppler recording
Sponsor: Hospices Civils de Lyon
Recruiting - Condition: Asthma
Interventions: Drug: vitamin D3 4000 IU; Drug: Placebo
Sponsors: Juan Celedon, MD; Pharmavite; National Heart, Lung, and Blood Institute (NHLBI)
Recruiting - Conditions: Prostate Cancer; Prostate Neoplasms; Neoplasms, Prostatic
Interventions: Biological: PROSTVAC-V; Biological: PROSTVAC-F; Drug: Docetaxel
Sponsor: National Cancer Institute (NCI)
Recruiting - Conditions: Pre-diabetes; Metabolic Syndrome
Interventions: Dietary Supplement: Active; Dietary Supplement: Control
Sponsor: Institute for Food Safety and Health, United States
Recruiting - Condition: Stress Disorders, Post-traumatic
Interventions: Behavioral: Trauma Sensitive Yoga Intervention; Behavioral: Cognitive Processing Therapy-Cognitive Only
Sponsor: VA Office of Research and Development
Recruiting - Condition: Atopic Dermatitis
Interventions: Procedure: Skin Biopsy; Procedure: Skin tape stripping; Procedure: Blood draw
Sponsors: National Jewish Health; MedImmune LLC
Recruiting - Conditions: Asthma; Rhinovirus; Picornaviridae Infections; Common Cold
Interventions: Drug: OC459; Drug: Placebo; Other: Rhinovirus
Sponsors: Imperial College London; Medical Research Council; Atopix Therapeutics, Ltd.
Recruiting - Condition: Adolescent Substance Use
Interventions: Behavioral: Teen Intervene; Behavioral: Everyday Parenting
Sponsors: University of Minnesota - Clinical and Translational Science Institute; National Institute on Drug Abuse (NIDA); Natalis Counseling Center
Recruiting - Conditions: High Grade Ovarian Serous Adenocarcinoma; Ovarian Endometrioid Tumor; Recurrent Fallopian Tube Carcinoma; Recurrent Ovarian Carcinoma; Recurrent Primary Peritoneal Carcinoma; Stage IV Fallopian Tube Cancer AJCC v6 and v7; Stage IV Ovarian Cancer AJCC v6 and v7; Stage IV Primary Peritoneal Cancer AJCC v7
Interventions: Drug: ATR Kinase Inhibitor VX-970; Drug: Carboplatin; Drug: Gemcitabine Hydrochloride; Other: Laboratory Biomarker Analysis; Other: Pharmacological Study
Sponsor: National Cancer Institute (NCI)
Recruiting - Conditions: Adverse Reaction to Drug; Allergic Reaction to Contrast Media
Intervention: Drug: Gadoteric Acid
Sponsor: St. Louis University
Recruiting - Condition: Metastatic Breast Cancer
Interventions: Drug: Vinorelbine; Drug: DDP
Sponsor: Fudan University
Recruiting - Condition: Hypersensitivity
Interventions: Drug: Mometasone furoate drug formulation (MFF) 1; Drug: Mometasone furoate drug formulation (MFF) 2
Sponsors: University of Florida; Food and Drug Administration (FDA)
Not yet recruiting - Conditions: Asthma; Allergic Rhinitis
Intervention: Other: Lung Function Assessment
Sponsor: Stefania La Grutta, MD
Recruiting - Condition: Asthma
Interventions: Drug: Mannitol; Drug: Methacholine; Drug: Placebo; Other: Rest; Other: Exercise
Sponsor: University of Alberta
Recruiting - Condition: Nasopharyngeal Cancinoma (NPC)
Intervention:
Sponsor: National Cancer Institute (NCI)
Recruiting - Condition: Palmar-Plantar Erythrodysesthesia
Interventions: Device: Vitamin B6 cream; Device: Placebo Vitamin B6 cream
Sponsors: Cyprus University of Technology; American Medical Center
Recruiting - Condition: Ovarian Carcinoma
Interventions: Drug: Tamoxifen; Drug: Regorafenib
Sponsors: ARCAGY/ GINECO GROUP; Bayer
Recruiting - Conditions: Asthma; Hyperinflation
Intervention: Procedure: Bronchial thermoplasty for treatment of severe asthma
Sponsor: University Hospital, Toulouse
Recruiting - Condition: Colon Adenocarcinoma
Interventions: Drug: Carbon C 14 Oxaliplatin; Drug: Oxaliplatin
Sponsors: University of California, Davis; National Cancer Institute (NCI)
Recruiting - Condition: Eclampsia
Intervention:
Sponsor: Medical University of Graz
Recruiting - Condition: Eosinophilic Esophagitis (EoE)
Interventions: Drug: OBS; Drug: Placebo
Sponsor: Shire
Recruiting - Condition: Eosinophilic Esophagitis
Interventions: Device: Cytosponge; Other: Diet; Other: Phone call; Other: EEsAI Pro
Sponsor: Mayo Clinic
Recruiting - Conditions: Vasculitis; Behcet's Disease; CNS Vasculitis; Cryoglobulinemic Vasculitis; Eosinophilic Granulomatosis With Polyangiitis (EGPA); Churg-Strauss Syndrome (CSS); Granulomatosis With Polyangiitis (GPA); Wegener's Granulomatosis; IgA Vasculitis; Henoch-Schoenlein Purpura (HSP); Microscopic Polyangiitis (MPA); Polyarteritis Nodosa (PAN); Takayasu Arteritis (TAK); Urticarial Vasculitis; Systemic Vasculitis
Intervention: Other: Online questionnaires
Sponsors: University of Pennsylvania; Duke University; University of South Florida
Recruiting - Conditions: Patch,Chinese Herb; Moxibustion; Allergic Rhinitis
Interventions: Drug: Sanfu herbal patch; Drug: Sanfu moxibustion; Drug: Sanfu herbal patch and moxibustion
Sponsor: Hubei Provincial Collaborative Innovation Center of Preventive Treatment by Acupuncture and Moxibust
Recruiting - Condition: Dermatitis, Atopic
Intervention: Other: Bathing Additive
Sponsor: Mayo Clinic
Recruiting - Conditions: Vocal Cord Tension; Dysfluency Developmental
Intervention: Other: Food Allergy Testing and Elimination Diet
Sponsor: The R2 Institute
Not yet recruiting - Conditions: Acute Leukemia of Ambiguous Lineage; Recurrent Adult Acute Lymphoblastic Leukemia; Recurrent Adult Acute Myeloid Leukemia; Recurrent Childhood Acute Lymphoblastic Leukemia; Recurrent Childhood Acute Myeloid Leukemia; Refractory Acute Myeloid Leukemia; Refractory Adult Acute Lymphoblastic Leukemia; Refractory Childhood Acute Lymphoblastic Leukemia
Interventions: Other: Chemosensitivity Assay; Other: Cytology Specimen Collection Procedure; Genetic: Gene Expression Analysis; Genetic: Genetic Variation Analysis; Drug: In Vitro Sensitivity-Directed Chemotherapy
Sponsors: University of Washington; National Cancer Institute (NCI)
Recruiting - Condition: Esophageal Diseases
Interventions: Drug: Dronabinol; Drug: Placebo
Sponsor: Temple University
Recruiting - Conditions: Adverse Drug Event; Adverse Drug Reaction; Chinese Medicine; Anaphylactic Reaction
Intervention: Drug: Breviscapine Powder-Injection
Sponsor: Zhong Wang
Recruiting - Condition: Asthma
Interventions: Drug: Omalizumab; Drug: Placebo
Sponsor: Wanda Phipatanakul
Not yet recruiting - Condition: Asthma
Interventions: Drug: QVM149; Drug: QMF149; Drug: salmeterol/fluticasone
Sponsor: Novartis Pharmaceuticals
Recruiting - Condition: Asthma
Intervention: Other: 1 year Observational Follow-up
Sponsor: University of Pittsburgh
Recruiting - Condition: Breast Cancer
Interventions: Device: KIBUR MICRODEVICE; Drug: anthracycline and taxane based chemotherapy
Sponsor: Memorial Sloan Kettering Cancer Center
Recruiting - Condition: Asthma
Interventions: Drug: QAW039; Drug: Placebo
Sponsor: Novartis Pharmaceuticals
Recruiting - Condition: Severe Eosinophilic Asthma
Interventions: Drug: OC000459; Drug: Placebo
Sponsor: Atopix Therapeutics, Ltd.
Recruiting - Condition: Asthma
Interventions: Biological: Mepolizumab 100mg; Drug: Placebo
Sponsor: GlaxoSmithKline
Recruiting - Condition: Asthma
Interventions: Drug: QAW039; Drug: Placebo
Sponsor: Novartis Pharmaceuticals
Recruiting - Conditions: Very Long-chain Acyl-CoA Dehydrogenase Deficiency; Trifunctional Protein Deficiency; Long-chain 3-hydroxyacyl-CoA Dehydrogenase Deficiency; Medium-chain Acyl-CoA Dehydrogenase Deficiency; Normal Volunteers
Interventions: Drug: Intralipid/Heparin; Drug: Glycerol/Saline; Drug: Hyperinsulinemic euglycemic clamp
Sponsor: Oregon Health and Science University
Recruiting - Conditions: Food Allergy; Loeys-Dietz Syndrome
Intervention:
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - Condition: Asthma
Interventions: Drug: QMF149; Drug: MF 400; Drug: salmeterol /fluticasone
Sponsor: Novartis Pharmaceuticals
Recruiting - Conditions: Hypersensitivity, Immediate; Insect Bites and Stings; Mastocytosis
Intervention:
Sponsor: Meir Medical Center
Recruiting - Conditions: Allergy to Fish; Allergy to Shrimp; Allergy to Crab
Interventions: Dietary Supplement: Treatment - Chinese Herbal Formula - X; Dietary Supplement: Placebo
Sponsors: Hong Kong Sanatorium & Hospital; Chinese University of Hong Kong
Recruiting - Condition: Atopic Dermatitis
Interventions: Drug: Cholecalciferol; Drug: Placebo of cholecalciferol
Sponsor: Rennes University Hospital
Recruiting - Condition: Henoch-Schoenlein Purpura
Interventions: Drug: Dexamethasone; Drug: Gamma globulin; Procedure: Hemoperfusion
Sponsor: Nanjing Children's Hospital
Recruiting - Conditions: Asthma; Wheeze; Hypersensitivity; Endophenotype
Intervention:
Sponsors: Klinikum der Universitaet Muenchen; German Federal Ministry of Education and Research; German Center for Lung Research; Comprehensive Pulmonary Center Munich; Airway Research Center North; Biomedical Research in Endstage and Obstructive Lung Disease Hannover; Translational Lung Research Center Heidelberg; Universities of Giessen and Marburg Lung Center
Recruiting - Condition: Egg Hypersensitivity
Intervention: Behavioral: shorter or longer period of specific dietary restrictions
Sponsors: Dominque Bullens; Jessa Hospital; Algemeen Ziekenhuis Maria Middelares; Imelda Hospital, Bonheiden; AZ Sint-Jan AV
Recruiting - Condition: Gastric and Cardia Adenocarcinomas
Intervention: Procedure: Biopsy
Sponsor: University Hospital, Strasbourg, France
Recruiting - Condition: Henoch-Schoenlein Purpura Nephritis
Interventions: Drug: Prednisone; Drug: Cyclophosphamide(CTX); Drug: Mycophenolate mofetil(MMF); Drug: Leflunomide(LEF); Drug: Angiotensin-converting enzyme inhibitor(ACEI); Drug: Methylprednisolone
Sponsor: Nanjing Children's Hospital
Recruiting - Condition: Henoch-Schoenlein Purpura Nephritis
Interventions: Drug: Prednisone; Drug: ACEI
Sponsor: Nanjing Children's Hospital
Recruiting - Conditions: Hypotension; Postoperative Complications; Acute Coronary Syndrome; Heart Failure; Coronary Occlusion; Stroke; Acute Kidney Injury; Renal Insufficiency, Chronic; Death
Interventions: Drug: Liberal blood pressure management; Drug: Tight blood pressure management
Sponsor: Miodrag Filipovic, Prof. Dr. med.
Recruiting - Conditions: Ovarian Cancer; Fallopian Tube Cancer; Neoadjuvant Treatment; Debulking Surgical Procedures
Interventions: Drug: Olaparib; Drug: Platinum-based Chemotherapy
Sponsor: University Health Network, Toronto
Recruiting - Condition: Dermatitis, Allergic Contact
Intervention: Other: Patch Test
Sponsors: Winthrop University Hospital; Smart Practice
Recruiting - Condition: Asthma
Intervention:
Sponsors: National Institute of Allergy and Infectious Diseases (NIAID); Inner-City Asthma Consortium
Recruiting - Condition: BRCA or HRR+ Mutated Ovarian Cancer Patients
Intervention: Drug: Olaparib
Sponsor: AstraZeneca
Recruiting - Condition: Neoplasm
Intervention: Drug: Crizotinib
Sponsor: Pfizer
Available - Condition: Cough
Intervention: Other: Citric Acid
Sponsors: Mayo Clinic; University of Manchester
Recruiting - Condition: Healthy
Intervention: Device: Polarization-Sensitive OFDI
Sponsors: Massachusetts General Hospital; Massachusetts Eye and Ear Infirmary
Not yet recruiting - Conditions: Aortic Stenosis; Heart Failure; Syncope; Angina Pectoris
Intervention: Procedure: Aortic Valve Intervention (surgical or transcatheter)
Sponsor: Medical University Innsbruck
Recruiting - Condition: Cough
Interventions: Drug: Pregabalin; Drug: Control-Placebo
Sponsor: Ottawa Hospital Research Institute
Recruiting - Conditions: BRCA Rearrangement; Deleterious BRCA1 Gene Mutation; Deleterious BRCA2 Gene Mutation; Fallopian Tube Clear Cell Adenocarcinoma; Fallopian Tube Transitional Cell Carcinoma; Ovarian Clear Cell Adenocarcinoma; Ovarian Endometrioid Tumor; Ovarian Seromucinous Carcinoma; Ovarian Serous Tumor; Ovarian Transitional Cell Carcinoma; Recurrent Fallopian Tube Carcinoma; Recurrent Ovarian Carcinoma; Recurrent Primary Peritoneal Carcinoma; Undifferentiated Fallopian Tube Carcinoma; Undifferentiated Ovarian Carcinoma
Interventions: Drug: Carboplatin; Drug: Cediranib Maleate; Drug: Gemcitabine Hydrochloride; Other: Laboratory Biomarker Analysis; Drug: Olaparib; Drug: Paclitaxel; Drug: Pegylated Liposomal Doxorubicin Hydrochloride; Other: Pharmacological Study; Other: Quality-of-Life Assessment
Sponsors: National Cancer Institute (NCI); AstraZeneca
Recruiting - Condition: Rhinitis, Allergic, Seasonal
Interventions: Biological: MK-3641; Biological: Placebo; Drug: Self-injectable epinephrine; Drug: Albuterol/Salbutamol; Drug: Loratadine; Drug: Olopatadine; Drug: Mometasone furoate monohydrate
Sponsor: Merck Sharp & Dohme Corp.
Recruiting - Condition: Non-celiac Wheat Sensitivity
Intervention:
Sponsor: University of Palermo
Recruiting - Condition: Non-celiac Wheat Sensitivity
Intervention:
Sponsor: University of Palermo
Recruiting - Condition: Non-Celiac Wheat Sensitivity
Intervention:
Sponsor: University of Palermo
Recruiting - Condition: Asthma
Intervention:
Sponsor: National Heart, Lung, and Blood Institute (NHLBI)
Recruiting - Condition: Asthma
Intervention: Device: Bronchial thermoplasty with the Alair System
Sponsor: University Hospital, Strasbourg, France
Recruiting - Condition: Asthma
Interventions: Device: AccuPAP; Drug: Albuterol and Ipratropium Continuous Nebulizer
Sponsor: Vanderbilt University Medical Center
Recruiting - Condition: Hypothyroidism
Intervention: Drug: Levothyroxine
Sponsor: All India Institute of Medical Sciences, Bhubaneswar
Recruiting - Condition: Bronchial Asthma
Interventions: Drug: Intravenous magnesium sulfate; Drug: Inhaled budesonide; Drug: normal saline
Sponsor: Hamad Medical Corporation
Recruiting - Condition: Eosinophilic Esophagitis
Intervention:
Sponsor: University of Colorado, Denver
Recruiting - Condition: Allergic Bronchopulmonary Aspergillosis
Interventions: Drug: Itraconazole; Drug: Glucocorticoids
Sponsor: Postgraduate Institute of Medical Education and Research
Recruiting - Condition: Asthma
Interventions: Behavioral: Targeted text messages; Behavioral: General text messages
Sponsors: Children's Hospitals and Clinics of Minnesota; HealthPartners Institute
Recruiting - Condition: Arthritis, Rheumatoid
Intervention:
Sponsors: Guang'anmen Hospital of China Academy of Chinese Medical Sciences; National Natural Science Foundation of China
Recruiting - Condition: Eosinophilic Esophagitis
Intervention: Other: Antigen (wheat base soy sauce) spray
Sponsor: Mayo Clinic
Recruiting - Conditions: Hypertension; Stress, Psychological; Blood Pressure
Interventions: Drug: Prazosin; Drug: Placebo
Sponsors: Augusta University; The University of Texas at Arlington
Recruiting - Condition: Lung Neoplasms
Intervention: Other: ALK analysis on CTCs detected by ISET
Sponsor: Centre Hospitalier Universitaire de Nice
Recruiting - Conditions: Hypertension; Obesity; Stress, Psychological; Blood Pressure
Interventions: Drug: Irbesartan; Other: Placebo
Sponsor: Augusta University
Recruiting - Conditions: Irritable Bowel Syndrome; Visceral Hypersensitivity
Interventions: Procedure: Gastrointestinal Permeability Test; Procedure: Upper Endoscopy; Procedure: Rectal Barostat and Infusion of Fats
Sponsors: Mayo Clinic; University of Erlangen-Nürnberg; Heidelberg University
Recruiting - Conditions: Obesity; Insulin Resistance
Interventions: Procedure: Fat biopsy during scheduled abdominal surgery; Procedure: Fat Aspiration; Dietary Supplement: Fish Oil Supplement
Sponsor: Mayo Clinic
Recruiting - Condition: Asthma
Intervention: Biological: Segmental Bronchoprovocation with Allergen (SBP-Ag)
Sponsors: Lu Yuan Lee; National Institute of Allergy and Infectious Diseases (NIAID)
Not yet recruiting - Conditions: Obesity; Insulin Resistance; Insulin Sensitivity; Beta-Cell Dysfunction; Prediabetes
Interventions: Dietary Supplement: Placebo; Dietary Supplement: Low-Dose Vitamin K2 Supplement (menaquinone-7; 90-mcg/d); Dietary Supplement: High-Dose Vitamin K2 Supplement (menaquinone-7; 180-mcg/d)
Sponsors: Augusta University; University of Alabama at Birmingham; Yale University; Tufts University; Nattopharma ASA
Recruiting - Conditions: Food Allergy; Wheat Allergy
Intervention:
Sponsors: University of Colorado, Denver; Monsanto Company, LLC
Recruiting - Condition: Advanced Stage Non-small Cell Lung Cancer
Interventions: Drug: nivolumab; Drug: pilimumab
Sponsors: Memorial Sloan Kettering Cancer Center; Bristol-Myers Squibb
Recruiting - Conditions: Impairment of Oral Perception; Insulin Resistance
Interventions: Dietary Supplement: Sucralose; Dietary Supplement: Sucrose; Dietary Supplement: Sucralose + maltodextrin; Dietary Supplement: Sucralose + Sucrose
Sponsor: Yale University
Recruiting - Conditions: Esophageal Stricture; Eosinophilic Esophagitis; Zenkers Diverticulum; Schatzki Ring
Intervention: Device: EndoFLIP
Sponsor: University of Pennsylvania
Recruiting - Conditions: Cat Allergy; Cat Hypersensitivity
Interventions: Drug: Cat-PAD; Drug: Placebo
Sponsors: National Institute of Allergy and Infectious Diseases (NIAID); Circassia Limited
Recruiting - Condition: Colorectal Cancer
Intervention: Procedure: Flexible sigmoidoscopy or colonoscopy
Sponsors: Dr. Frank ter Borg MD PhD; Erasmus Medical Center; The Netherlands Cancer Institute; Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA); UMC Utrecht
Recruiting - Condition: Non Coeliac Gluten Sensitivity
Interventions: Other: Normal gluten containing bread; Other: Bread with reduced gliadins content; Other: Bread with reduced ATIs content; Other: Bread with reduced overall protein content
Sponsor: University of Aberdeen
Recruiting - Condition: Asthma
Intervention: Other: Hyperpolarized Noble Gas MRI
Sponsor: Dr. Grace Parraga
Recruiting - Conditions: Hormone Sensitive Prostate Cancer; Prostate Cancer; Cancer of the Prostate
Interventions: Drug: Enzalutamide; Drug: Placebo; Drug: Leuprolide
Sponsors: Pfizer; Astellas Pharma Inc; Medivation, Inc.
Recruiting - Condition: Hymenoptera Allergy
Interventions: Procedure: biological sampling; Biological: Desensitization protocol (Alyostall®)
Sponsor: University Hospital, Rouen
Recruiting - Condition: Rhinitis, Allergic, Perennial
Interventions: Other: acupuncture combined moxibustion; Drug: Loratadine
Sponsors: Zhao Hong; China Academy of Chinese Medical Sciences; Beijing Municipal Science & Technology Commission
Recruiting - Condition: Platinum-Sensitive Ovarian Cancer in First Relapse
Interventions: Drug: Farletuzumab; Drug: Placebo
Sponsors: Morphotek; Eisai Co., Ltd.
Recruiting - Condition: Asthma
Intervention:
Sponsor: National Institute of Environmental Health Sciences (NIEHS)
Recruiting - Conditions: Atopic Dermatitis; Food Allergies
Interventions: Drug: B. infantis; Drug: Placebo
Sponsor: Emanual Maverakis, MD
Recruiting - Condition: Relapsed Ovarian Cancer, BRCA Mutation, Platinum Sensitivity
Interventions: Drug: OLAPARIB; Drug: Single agent chemotherapy
Sponsors: AstraZeneca; Myriad Genetic Laboratories, Inc.
Recruiting - Condition: Chronic Rhinosinusitis
Interventions: Drug: Itraconazole; Drug: Placebo
Sponsor: The University of Texas Health Science Center, Houston
Recruiting - Condition: Toxic Epidermal Necrolysis
Interventions: Drug: Clobetasol 0.05% ointment; Drug: Placebo
Sponsor: University of California, Davis
Recruiting - Conditions: Adenocarcinoma of the Prostate; Recurrent Prostate Cancer; Stage III Prostate Cancer; Stage IV Prostate Cancer
Interventions: Drug: Enzalutamide; Drug: leuprolide acetate; Drug: goserelin acetate; Drug: histrelin acetate; Drug: triptorelin; Drug: degarelix
Sponsor: University of Colorado, Denver
Recruiting - Condition: Henoch Schönlein Purpura
Interventions: Biological: Blood samples; Biological: Stool samples
Sponsor: Centre Hospitalier Universitaire de Nīmes
Recruiting - Condition: Colon Cancer
Intervention: Drug: Omalizumab
Sponsor: Yale University
Recruiting - Condition: Sleep Apnea
Intervention:
Sponsor: University of Texas Southwestern Medical Center
Recruiting - Condition: Asthma
Interventions: Behavioral: AIM2ACT; Behavioral: Self-guided
Sponsors: University of Florida; The Miriam Hospital; Rhode Island Hospital; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Recruiting - Condition: Asthma
Interventions: Other: integrated pest management; Other: air purifier; Other: No intervention (control)
Sponsors: Boston Children’s Hospital; National Institutes of Health (NIH); National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - Condition: Pulmonary Tuberculosis
Interventions: Drug: PA-824; Drug: Rifampin; Drug: Rifabutin; Drug: Pyrazinamide; Drug: Ethambutol; Drug: Isoniazid
Sponsor: Johns Hopkins University
Recruiting - Condition: Asthma
Interventions: Behavioral: Mindfulness Based Stress Reduction (MBSR); Behavioral: Healthy Living Course (HLC)
Sponsors: University of Massachusetts, Worcester; The Miriam Hospital
Recruiting - Conditions: Atopic Dermatitis; Acne Rosacea; Acne Vulgaris
Intervention:
Sponsor: Innovaderm Research Inc.
Recruiting - Conditions: Stroke; Brain Infarction; Brain Ischemia; Cerebral Infarction; Cerebrovascular Disorders
Interventions: Behavioral: Early Intensive upper extremity motor training; Behavioral: Sub-acute intensive upper extremity motor training; Behavioral: Chronic intensive upper extremity motor training; Behavioral: Control
Sponsors: MedStar National Rehabilitation Network; Georgetown University; University of Wisconsin, Madison; The Catholic University of America; Medstar Health Research Institute
Recruiting - Condition: Asthma
Interventions: Other: NO2 Scrubber; Other: HEPA filter; Other: Control
Sponsors: Yale University; Harvard University; National Institute of Environmental Health Sciences (NIEHS)
Recruiting - Condition: Asthma
Interventions: Drug: Flovent Diskus; Other: Home Environmental Intervention; Drug: Advair Diskus
Sponsor: Johns Hopkins University
Recruiting - Condition: Not-celiac Gluten Sensitivity
Intervention:
Sponsor: University of Palermo
Recruiting - Condition: Asthma
Intervention: Procedure: Bronchial Thermoplasty
Sponsor: University of Oklahoma
Recruiting - Conditions: Peanut Allergies; Tree Nut Allergies; Other Food Allergies
Intervention:
Sponsors: University of Colorado, Denver; National Institutes of Health (NIH)
Recruiting - Condition: Peanut Allergy
Intervention:
Sponsors: Weill Medical College of Cornell University; Yale University
Recruiting - Condition: Rejection Sensitivity
Intervention:
Sponsors: Stony Brook University; University of Michigan; National Institute of Mental Health (NIMH)
Recruiting - Condition: Asthma
Intervention: Biological: Segmental airway allergen challenge
Sponsors: University of California, San Francisco; National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - Conditions: Pompe Disease; Hypersensitivity Reaction
Intervention: Drug: Zavesca® Prescription
Sponsors: University of Florida; Amicus Therapeutics
Recruiting - Condition: Eosinophilic Esophagitis
Intervention: Device: SECM Capsule
Sponsors: Massachusetts General Hospital; National Institutes of Health (NIH); National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Recruiting - Condition: Signs and Symptoms
Intervention: Device: Acoustic Angiography
Sponsors: UNC Lineberger Comprehensive Cancer Center; National Cancer Institute (NCI)
Recruiting - Condition: Asthma
Interventions: Behavioral: School-Based Asthma Care for Teens (SB-ACT); Behavioral: Directly Observed Therapy; Behavioral: Asthma Education
Sponsors: University of Rochester; National Heart, Lung, and Blood Institute (NHLBI)
Recruiting - Conditions: Barrett's Esophagus; Eosinophilic Esophagitis
Intervention: Device: OFDI Capsule
Sponsors: Massachusetts General Hospital; National Institutes of Health (NIH); National Cancer Institute (NCI)
Recruiting - Condition: Polycystic Ovarian Syndrome
Interventions: Other: Paleolithic diet; Other: American Diabetes Association diet
Sponsor: University of California, San Francisco
Recruiting - Condition: Hypersensitivity
Interventions: Device: Sensodyne; Device: Crest Cavity Protection & MI Paste Plus; Device: Clinpro 5000
Sponsor: Tufts University School of Dental Medicine
Recruiting - Condition: Asthma
Interventions: Other: Interactive SMS; Other: Usual care
Sponsors: University of British Columbia; WelTel; College of Pharmacists of British Columbia; Canadian Institutes of Health Research (CIHR)
Recruiting - Conditions: Acute Lymphoblastic Leukemia; B Acute Lymphoblastic Leukemia; B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1; B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative; Philadelphia Chromosome Positive; Recurrent Adult Acute Lymphoblastic Leukemia; Refractory Adult Acute Lymphoblastic Leukemia; Untreated Adult Acute Lymphoblastic Leukemia
Interventions: Biological: Blinatumomab; Drug: Dasatinib; Other: Laboratory Biomarker Analysis; Drug: Mercaptopurine; Drug: Methotrexate; Drug: Prednisone; Drug: Vincristine Sulfate
Sponsor: National Cancer Institute (NCI)
Recruiting - Condition: Insulin Sensitivity
Interventions: Drug: Maltodextrin; Drug: Synbiotic; Drug: Sevelamer
Sponsors: The University of Texas Health Science Center at San Antonio; American Diabetes Association
Recruiting - Condition: Food Allergy
Interventions: Drug: Vitamin D; Drug: placebo
Sponsor: Murdoch Childrens Research Institute
Recruiting - Condition: Insulin Sensitivity
Interventions: Drug: Sevelamer; Drug: Synbiotic; Drug: Maltodextrin
Sponsors: The University of Texas Health Science Center at San Antonio; American Diabetes Association
Recruiting - Condition: Allergic Rhinoconjunctivitis
Intervention: Biological: Immunotherapy
Sponsor: Medical University of Graz
Recruiting - Condition: Platinum Sensitive Recurrent High-grade Serous Ovarian Cancer With Mutated p53
Interventions: Drug: APR-246; Drug: Carboplatin and Pegylated Liposomal Doxorubicin Hydrochloride (PLD)
Sponsor: Aprea Therapeutics AB
Recruiting - Condition: Asthma
Intervention: Drug: dupilumab SAR231893 (REGN668)
Sponsors: Sanofi; Regeneron Pharmaceuticals
Recruiting - Condition: Low Dose Methotrexate in Severe Chronic Asthma
Interventions: Drug: Methotrexate; Drug: Placebo
Sponsor: Universita degli Studi di Catania
Not yet recruiting - Condition: Asthma
Intervention:
Sponsor: University of California, San Francisco
Recruiting - Conditions: Skipping Breakfast; Circadian Rhythms
Interventions: Other: 3 standard meals/day; Other: 2 meals/day (omit breakfast)
Sponsor: Washington University School of Medicine
Recruiting - Condition: Pediatric Fractures
Intervention:
Sponsor: Universitätsklinikum Hamburg-Eppendorf
Recruiting - Condition: Type 2 Diabetes
Intervention: Other: High intensity interval training
Sponsor: German Diabetes Center
Recruiting - Conditions: Hepatitis C; Hepatitis B; Nonalcoholic Fatty Liver Disease (NAFLD); Nonalcoholic Steatohepatitis (NASH)
Intervention: Device: Transient elastography, acoustic radiation force impulse, magnetic resonance elastography
Sponsors: Centre hospitalier de l'Université de Montréal (CHUM); Canadian Institutes of Health Research (CIHR); Centre de Recherche du Centre Hospitalier de l'Université de Montréal
Recruiting - Condition: Low Back Pain
Intervention:
Sponsor: University of Belgrade
Recruiting - Conditions: Lung Diseases; Medication Compliance
Interventions: Drug: Fluticasone propionate 230mcg for 3 Months; Drug: Current Treatment or no treatment; Drug: Salmeterol 21mcg for 3 Months
Sponsors: New York University School of Medicine; National Institute for Occupational Safety and Health (NIOSH/CDC)
Recruiting - Condition: Obesity
Intervention: Other: Exercise
Sponsors: University of Michigan; American Diabetes Association
Recruiting - Condition: Eosinophilic Esophagitis
Intervention:
Sponsors: University of Colorado, Denver; University of Illinois at Chicago; Northwestern University; OSF St. Francis Medical Center
Recruiting - Condition: Asthma
Interventions: Drug: Azithromycin; Drug: Placebo
Sponsor: Montefiore Medical Center
Recruiting - Conditions: Obesity; Insulin Resistance; Insulin Sensitivity; Prediabetes; Dyslipidemia; Diabetes
Interventions: Dietary Supplement: Placebo-Control; Dietary Supplement: Low-Dose Vitamin K2 (menaquinone-7; 45 mcg/d); Dietary Supplement: High-Dose Vitamin K2 (menaquinone-7; 90 mcg/d)
Sponsors: Augusta University; University of Alabama at Birmingham; Yale University; Tufts University; Nattopharma ASA
Recruiting - Conditions: Diarrhea; Atopic Dermatitis
Intervention: Dietary Supplement: Probiotic
Sponsor: Nestlé
Recruiting - Condition: Soy Allergy
Intervention: Other: Oral food challenge
Sponsor: University of Colorado, Denver
Recruiting - Conditions: Small Cell Lung Carcinoma; Non Small Cell Lung Carcinoma; Irinotecan Sensitive Cancers
Interventions: Drug: Carfilzomib; Drug: Irinotecan
Sponsors: Cancer Research and Biostatistics Clinical Trials Consortium; Lucille P. Markey Cancer Center at University of Kentucky; Washington University School of Medicine
Recruiting - Conditions: Migraine Disorders; Photophobia
Intervention: Device: Investigational Coating
Sponsors: University of Utah; Primary Children's Hospital
Recruiting - Conditions: Middle Ear Disease; Nasal Allergy
Interventions: Biological: ragweed; Biological: histamine; Drug: pseudoephedrine; Drug: Oxymetazoline
Sponsors: Cuneyt M. Alper; National Institute on Deafness and Other Communication Disorders (NIDCD)
Recruiting - Condition: Tuberculosis
Interventions: Drug: Isoniazid; Dietary Supplement: Vitamin B6
Sponsors: AIDS Clinical Trials Group; National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - Condition: Eosinophilic Esophagitis
Intervention: Device: Mucosal Impedance
Sponsor: Mayo Clinic
Recruiting - Condition: Pain
Intervention: Drug: Duloxetine
Sponsors: University of Utah; American Cancer Society, Inc.
Recruiting - Conditions: Celiac Disease; Celiac Sprue; Gluten Enteropathy; Gluten-Sensitive Enteropathy
Intervention: Biological: Hu-Mik- Beta-1
Sponsors: National Cancer Institute (NCI); Mayo Clinic
Recruiting - Condition: Asthma
Intervention:
Sponsors: University of Wisconsin, Madison; National Institutes of Health (NIH); National Heart, Lung, and Blood Institute (NHLBI)
Recruiting - Conditions: Food Allergy; Eosinophilic Esophagitis
Intervention:
Sponsors: Children's Hospital of Philadelphia; University of Pennsylvania; National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - Condition: Not-celiac Wheat Sensitivity
Interventions: Dietary Supplement: wheat flour; Dietary Supplement: Xylose
Sponsor: University of Palermo
Recruiting - Conditions: Ovarian Cancer; Fallopian Tubes Cancer; Peritoneal Cancer
Interventions: Procedure: Secondary Cytoreductive Surgery; Drug: Carboplatin Hyperthermic Intraperitoneal Chemotherapy (HIPEC); Drug: platinum-based systemic chemotherapy postoperatively
Sponsors: Memorial Sloan Kettering Cancer Center; Mayo Clinic; Baptist Health South Florida; Hartford HealthCare; University of Pittsburgh; University of Chicago
Recruiting - Condition: Occupational Asthma
Intervention: Other: standardized bronchial challenge test (SCL SCL • • GenaSOL ™ GenaSIC ™)
Sponsor: University Hospital, Strasbourg, France
Recruiting - Conditions: Atopic Dermatitis; Eczema
Intervention:
Sponsors: Northwestern University; Rockefeller University
Recruiting - Condition: Asthma
Intervention:
Sponsor: National Heart, Lung, and Blood Institute (NHLBI)
Recruiting - Condition: Palmar-plantar Erythrodysesthesia (PPE)
Interventions: Drug: Henna; Drug: Placebo
Sponsor: Cyprus University of Technology
Recruiting - Condition: Pompe Disease
Intervention: Biological: alglucosidase alfa
Sponsor: Genzyme, a Sanofi Company
Recruiting - Condition: Cow Milk Allergy
Intervention: Dietary Supplement: Comparison of treatment with different amino acid formulas
Sponsor: Mahidol University
Recruiting - Condition: Cancer of the Uterine Cervix
Intervention: Device: 18F-FDG-PET
Sponsor: Hospices Civils de Lyon
Recruiting - Condition: Allergies
Intervention: Other: No Intervention
Sponsor: Stanford University
Recruiting - Conditions: Ovarian Epithelial Cancer Recurrent; Fallopian Tube Carcinoma; Primary Peritoneal Carcinoma
Interventions: Procedure: Secondary Cytoreductive Surgery; Drug: Salvage Chemotherapy
Sponsors: Shanghai Gynecologic Oncology Group; Fudan University; Zhejiang Cancer Hospital; Shanghai Zhongshan Hospital; Sun Yat-sen University
Recruiting - Condition: Dermatitis, Atopic
Interventions: Drug: Trimethoprim/sulfamethoxazole (TMP/SMZ); Drug: Cephalexin; Drug: Doxycycline; Other: Sodium hypochlorite
Sponsor: National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Recruiting - Condition: Type 2 Diabetes
Interventions: Drug: Acipimox; Drug: Placebo
Sponsors: University of Colorado, Denver; VA Office of Research and Development; Pfizer
Recruiting - Condition: Eosinophilic Esophagitis
Intervention: Device: Cytosponge - Brushing
Sponsors: Mayo Clinic; University of Cambridge
Recruiting - Conditions: Acute Rhinosinusitis; Allergic Rhinitis
Intervention:
Sponsor: Virginia Commonwealth University
Recruiting - Conditions: Obesity; Diabetes Mellitus, Non-Insulin-Dependent
Intervention: Procedure: surgery
Sponsors: German Diabetes Center; Dep.of General-, Visceral- and Pediatric Surgery, HHU, Duesseldorf; Dep.for Metabolic Diseases, HHU, Duesseldorf
Recruiting - Condition: Asthma
Intervention: Drug: Budesonide
Sponsors: University of California, San Francisco; National Heart, Lung, and Blood Institute (NHLBI)
Recruiting - Condition: Obesity
Intervention:
Sponsors: University of Michigan; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Recruiting - Condition: Acute Asthma
Interventions: Drug: Magnesium Sulfate Sandoz; Drug: Sodium Chloride , USP PPC
Sponsors: The Hospital for Sick Children; Canadian Institutes of Health Research (CIHR); Alberta Children's Hospital; St. Justine's Hospital; Children's Hospital of Eastern Ontario; Stollery Children's Hospital; The Children's Hospital of Winnipeg; Provincial Health Services Authority
Recruiting - Condition: Rheumatoid Arthritis
Intervention: Diagnostic Test: Synacthen test
Sponsor: Rigshospitalet, Denmark
Recruiting - Condition: Irritable Bowel Syndrome
Interventions: Drug: Mesalamine; Drug: Placebo
Sponsors: University of Utah; Shire Human Genetic Therapies, Inc.
Recruiting - Condition: Hereditary Angioedema
Intervention: Drug: rhC1INH or pdC1INH
Sponsor: Pharming Technologies B.V.
Recruiting - Condition: Asthma
Interventions: Behavioral: Motivational Communication; Behavioral: Control
Sponsors: Hopital du Sacre-Coeur de Montreal; Jewish General Hospital
Recruiting - Condition: Breast Cancer
Interventions: Procedure: Tumor Biopsy; Other: Breast Cancer Registry
Sponsor: M.D. Anderson Cancer Center
Recruiting - Condition: Asthma
Intervention: Drug: budesonide/formoterol or fluticasone/salmeterol in all asthmatics
Sponsor: Gelb, Arthur F., M.D.
Recruiting - Condition: Asthma
Intervention: Device: Alair system
Sponsors: Washington University School of Medicine; The Cleveland Clinic; National Jewish Health; University of Arizona; University of Chicago; Louisiana State University Health Sciences Center in New Orleans; University of Alabama at Birmingham; Creighton University
Recruiting - Condition: Atopic Dermatitis
Intervention:
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - Conditions: Healthy Control; Localized Urothelial Carcinoma of the Renal Pelvis and Ureter; Metastatic Malignant Neoplasm in the Bone; Metastatic Malignant Neoplasm in the Soft Tissues; Metastatic Urothelial Carcinoma of the Renal Pelvis and Ureter; Recurrent Bladder Carcinoma; Recurrent Prostate Carcinoma; Recurrent Urothelial Carcinoma of the Renal Pelvis and Ureter; Stage IV Bladder Cancer; Stage IV Bladder Urothelial Carcinoma; Stage IV Prostate Cancer
Interventions: Other: Cytology Specimen Collection Procedure; Other: Laboratory Biomarker Analysis
Sponsors: University of Washington; National Cancer Institute (NCI)
Recruiting - Conditions: Stroke; Insulin Resistance; Sedentary Lifestyle
Interventions: Behavioral: Aerobic Exercise; Behavioral: Stretching
Sponsors: Baltimore VA Medical Center; National Institute on Aging (NIA)
Recruiting - Conditions: Anaphylaxis; Hypotension; Bronchospasm; Angioedema
Interventions: Drug: Epinephrine; Procedure: Bone Marrow Apsiration; Drug: Omalizumab (Xolair)
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - Conditions: Autoinflammatory Syndromes; Physical Urticaria
Intervention:
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - Conditions: Piebaldism; Idiopathic Anaphylaxis; Allergy; Chronic Urticara; Angioedema
Intervention:
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - Condition: Congenital Hyperinsulinism
Interventions: Drug: exendin-(9-39); Other: placebo
Sponsor: Diva De Leon
Recruiting - Condition: Normal Volunteer Controls
Intervention:
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - Condition: Anaphylaxis
Intervention:
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - Conditions: Acne; Actinic Keratosis; Dysplastic Nevi; Eczema; Psoriasis; Skin Cancer; Rosacea; Leg Ulcers; Foot Ulcers; Atopic Dermatitis
Intervention:
Sponsor: University of California, Davis
Recruiting - Conditions: Atopic Dermatitis; Eczema; Ichthyosis Vulgaris
Intervention:
Sponsor: National Human Genome Research Institute (NHGRI)
Recruiting - Condition: Asthma
Intervention: Biological: Bronchoscopy, Segmental Allergen Challenge, and Broncheoalveolar Lavage
Sponsors: Andrew D. Luster, M.D.,Ph.D.; National Institutes of Health (NIH); U.S. Army Medical Research and Materiel Command
Recruiting - Condition: Asthma
Interventions: Drug: budesonide/formoterol; Drug: fluticasone/salmeterol; Drug: mometasone/formoterol; Drug: Prednisone
Sponsor: Gelb, Arthur F., M.D.
Recruiting - Condition: Atopic Dermatitis
Intervention: Drug: Pimecrolimus
Sponsors: Valeant Pharmaceuticals International, Inc.; Clinical Research Computing Unit (University of Pennsylvania)
Recruiting - Conditions: Asthma; COPD
Intervention: Drug: salbutamol
Sponsor: University of Saskatchewan
Recruiting - Conditions: Cutaneous T-cell Lymphoma; Sezary Syndrome; Mycosis Fungoides; Eczema; Atopic Dermatitis
Intervention: Other: Blood draw or skin biopsy
Sponsor: University of Pittsburgh
Recruiting - Conditions: Urticaria; Arthropathy; Lymphadenopathy; Nervous System Anomalies
Intervention:
Sponsor: National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Recruiting - Conditions: Asthma; Eosinophilia; Helminthiasis; Hypersensitivity; Parasitic Disease
Intervention:
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - Condition: Asthma
Intervention:
Sponsor: National Heart, Lung, and Blood Institute (NHLBI)
Recruiting